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ABSTRACT 
Kathryn E. Lancaster: Substance use and engagement across the HIV care continuum among 
female sex workers, a key population in Malawi 
 (Under the direction of William C. Miller) 
 
 The effect of substance use on optimal engagement across the HIV care continuum 
must be delineated to inform strategies that enhance HIV testing and treatment for female sex 
workers (FSW), a key population in sub-Saharan Africa for HIV transmission.  We 
characterize the HIV care continuum and evaluate the association between substance use 
with engagement in HIV testing and treatment among FSW in Lilongwe, Malawi. 
 From July through September 2014, we enrolled 200 FSW ≥18 years using venue-
based sampling into a cross-sectional evaluation to assess engagement in the HIV care 
continuum and substance use.  Seropositive FSW, identified using HIV rapid testing, 
received rapid CD4 counts and viral loads using dried blood spots.  We examined the 
associations of alcohol and marijuana use with lack of HIV infection awareness and sub-
optimal HIV treatment outcomes: lack of ART use among ART-eligible and viral 
nonsuppression. 
 FSW had a very high HIV seroprevalence of 69%.  Sixty-nine percent of HIV-
infected FSW had a history of HIV care, 52% reported current ART use, and 45% were 
virally suppressed.  Among HIV-infected FSW, 45% were non-hazardous drinkers, 28% 
were hazardous drinkers, 12% were harmful drinkers, and 15% were alcohol dependent.  We 
observed a dose-response relationship between increased alcohol use and lack of HIV 
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infection awareness.  The prevalence ratio for lack of HIV infection awareness in 
multivariable analysis was 1.14 (95% CI: 0.53, 2.45) among current marijuana users.  In 
multivariable analysis, FSW who were harmful drinkers or alcohol dependent were 1.9 (95% 
CI: 1.0, 3.8) times as likely to not use ART.  The bivariable prevalence ratio for FSW 
nonsuppressed was 2.0 (95% CI: 0.6, 6.5) among harmful drinkers and alcohol dependent 
FSW.  In multivariable analysis, FSW who were currently using marijuana were 1.9 (95% 
CI: 0.8, 4.6) times as likely to not use ART. 
 Alcohol use is an influential barrier to achieving optimal HIV testing and treatment 
outcomes, which are necessary to receive the clinical, immunological, and transmission 
benefits of therapy.  Prioritizing combination interventions to incorporate alcohol risk 
reduction strategies, in addition to other substances, will improve the uptake of HIV testing 
and treatment for HIV-infected FSW in Malawi. 
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CHAPTER I: SPECIFIC AIMS 
Substance use is highly prevalent among female sex workers (FSW) globally.[1-7]  
FSW often engage in substance use to facilitate soliciting clients, to self-medicate for 
depression and to cope with stigma and stress related to sex work.[1, 4, 8-10]  Substance 
using FSW have low condom usage and high rates of sexual abuse and sexually transmitted 
infections, which all disproportionately place substance using FSW at high-risk for HIV 
infection.[2, 11-13] 
FSW are considered a key population for HIV prevention and treatment, with 
approximately 60% of FSW undiagnosed and thus unable to be engaged into care and receive 
antiretroviral treatment (ART).  Expanded ART for FSW can improve health outcomes and 
ultimately onward transmission.[14-16]  This success depends on being fully engaged in the 
HIV care continuum: timely diagnosis, engagement in care, adherence on antiretroviral 
therapy, and retention.[17-20]  Full engagement is a particular challenge among FSWs in 
sub-Saharan Africa.[14, 21, 22] However to date, there are few interventions linking FSW to 
HIV testing and care and no interventions specifically focusing on increased access to ART. 
Commonly used substances, alcohol and marijuana, may be one important barrier to 
full engagement for FSW and likely one contributing cause of HIV risk among FSW and 
their clients.  The patterns of substance use and the pathways through which alcohol and 
marijuana use may affect the HIV care continuum must be clearly delineated to prevent 
FSW-related HIV acquisition and transmission.  We hypothesize that FSW who have a high 
levels of alcohol and marijuana use, will have less completion of the HIV care continuum 
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compared to FSW who do not have high levels of alcohol and marijuana use.  Identification 
of the patterns and pathways through which alcohol and marijuana use affects each point 
along the HIV care continuum will inform strategies to increase access to HIV testing, care, 
and treatment for FSW. 
For this dissertation, we conducted a cross-sectional evaluation to determine whether 
substance use, particularly alcohol and marijuana, among FSW significantly affects 
engagement in HIV testing, care, and treatment in Lilongwe, Malawi.  In Malawi, the most 
common substances used are alcohol and marijuana.[23, 24]  Recent systematic, nationally 
representative prevalence estimates for current alcohol and marijuana use are limited; 
nonetheless alcohol and marijuana are considered acceptable and inexpensive forms of 
intoxication in Malawi.[24-26]  Venue-based recruitment was used to recruit a sample of 
FSW.  Consented FSW participated in a face-to-face survey and received rapid HIV testing.  
Among the seropositive FSW, CD4 cell count and HIV-1 RNA levels were ascertained.  This 
study was supported by the well-established research infrastructure of UNC Project-Malawi 
in Lilongwe, Malawi.  The specific aims were addressed in three manuscripts: 
Aim 1: Characterize the HIV care continuum among FSW in Lilongwe, Malawi.   
Overview: We identified 200 FSW using venue-based recruitment to participate in a face-to-
face behavioral survey examining HIV testing history and engagement in HIV care and 
treatment.  HIV serostatus was confirmed for all enrolled FSW.  Seropositive FSW provide 
blood samples for ascertaining CD4 counts and plasma HIV-1 RNA levels. 
Aim 2: Evaluate and compare the associations of alcohol and marijuana use with 
HIV testing: awareness of HIV infection.   Overview: We assessed HIV infection 
awareness through a behavioral survey collecting HIV testing history.  Women will received 
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HIV rapid testing to confirm HIV serostatus.  We examined the relationships between 
alcohol and marijuana use, alone and together, and HIV infection awareness. 
Aim 3: Evaluate and compare the associations of alcohol and marijuana use with 
engagement into HIV treatment: current use of ART among ART eligible FSW and 
viral suppression.   Overview: Among women who are seropositive, virological and 
immunological status was determined.  FSW eligible for ART was based on Malawi’s 
Ministry of Health ART eligibility definition.[27]  Among the FSW that have initiated ART, 
ART adherence was assessed based on the primary goal of ART– viral suppression.[28]  
This dissertation is one of the first studies to assess the impact alcohol and marijuana 
use along each stage of the HIV care continuum among FSW, a key population 
disproportionately affected by HIV.  A future combination intervention increasing both 
substance use treatment and access to HIV testing and treatment for FSW will be informed 
by this study.   
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CHAPTER II: BACKGROUND AND SIGNIFICANCE 
HIV prevalence among FSW in sub-Saharan Africa 
HIV prevalence among FSW remains disproportionately high despite decades of 
prevention activities.  FSW have been a key prevention population for the HIV epidemic 
since the 1980’s.[29] Yet, these women still are disproportionately more likely to acquire 
HIV than all other women of reproductive age.[29-34]  Globally, the burden of HIV among 
FSW is approximately 12%.  When compared to other regions, Sub-Saharan Africa holds the 
highest HIV prevalence among FSW, at approximately 37%.[30]  FSW within generalized 
epidemics in sub-Saharan Africa have more than 12-times increased odds of living with HIV 
when compared to all women.[30]  FSW in Malawi carry one of the highest burdens of HIV 
at an estimated 70%.[30]  
Despite nearly 20 years of prevention efforts, FSW in sub-Saharan Africa continue to 
experience high incidence of HIV.[14, 30, 35]  The heightened risk for HIV acquisition and 
transmission among FSW functions through a complex lattice of behavioral, biological, and 
structural risks.[36]  Behavioral risk factors at the individual level are varied and 
numerous.[32]  FSW have high-risk sexual exposures– high rates of unprotected sex,[11, 31, 
37, 38] anal sex,[39, 40] different sexual partners,[6, 41] concurrent sexual partners,[6, 32, 
42] and substance use.[2, 4, 8, 13]  Biologically, the burden of sexually transmitted infections 
(STI), besides, HIV, in FSW is high.  Generally at any point in time, two-thirds of FSW in 
sub-Saharan Africa have a curable STI.[32]  This high prevalence of STIs and the synergist 
relationship between HIV and STIs only compounds the risk of HIV transmission.[43]  
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Indirectly, structural risk factors further exacerbate HIV acquisition and transmission as FSW 
are more likely to experience stigma and discrimination reducing their ability to access HIV 
care and treatment services.[14, 30, 36, 44]  Furthermore, the illicit nature, organization, and 
power dynamics of sex work limits FSW’s ability to negotiate for safer sexual practices.[35, 
36]  Prevention activities must be complemented with novel combination interventions, 
addressing behavioral, biological, and structural risk factors, for HIV-infected FSW in order 
to prevent further HIV transmission. 
FSW access to HIV care and treatment 
HIV-infected FSW infrequently access HIV care and treatment services.  Alarmingly, 
only one-third of FSW in sub-Saharan Africa receive adequate HIV prevention services, even 
fewer access HIV care and treatment services.[14, 21]  Approximately 60% of FSW in the 
region are unaware of their HIV infection and most FSW only learn of their infection at 
antenatal care clinics during pregnancy.[14, 21]   
A situation analysis conducted by the Family Planning Association of Malawi in 
2011, reported nearly 70% of the 913 FSW interviewed were unaware of their current HIV 
infection.[41]  Qualitative findings revealed that the majority of FSW avoided receiving HIV 
testing and counseling out of fear for their results.  Similar to other countries in the region, 
most FSW were aware of their HIV infection due to mandatory testing during pregnancy.  
The most common reason for voluntary HIV testing was because of frequent illnesses or 
deterioration of health.[41]  Identifying HIV-infected FSW is only the first of several critical 
steps of accessing HIV care and treatment.   
The proportion of FSW who are eligible or and access to ART is scarcely evaluated 
or documented.[14]  Despite the recognition that linking newly diagnosed FSW to HIV care 
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and treatment can decrease morbidity and mortality, and ultimately onward transmission,[14-
16] no interventions specifically focusing on increased access to ART for FSW in sub-
Saharan Africa were identified in a recent systematic review.[14]  The full effect of expanded 
ART cannot be achieved unless the myriad of barriers for engagement into care are FSW are 
identified and addressed. 
Barriers of engagement into HIV care and treatment for FSW in sub-Saharan Africa 
are poorly understood.  Although the challenges of engagement in care and treatment are 
well-described for many HIV-infected persons in sub-Saharan Africa,[45, 46]  FSW 
experience unique barriers that may further complicate HIV care.  The multilevel barriers for 
full engagement into the HIV care continuum among FSW have been documented in other 
HIV prevalent settings.  Figure 2.1 depicts an adaption of the social ecological framework 
describing structural, work environment, interpersonal, and individual level barriers 
identified among FSW in similar settings that are likely exacerbating HIV risk and limiting 
their ability to seek HIV testing, care and treatment in sub-Saharan Africa.   
Structural level barriers arising out of the illegal nature of their work, cultural factors, 
geographic, lack of economic and educational opportunities, and discrimination from 
community and healthcare providers likely force FSW out of the HIV care continuum.[15, 
16, 29, 32, 33, 44] The work environment where FSW solicit clients further impedes their 
ability to seek HIV care and treatment.  FSW who are street-based have higher prevalence of 
sexual risk behaviors and likely are less engaged for HIV care and treatment as most HIV 
surveillance activities focus on venue-based FSW.[47]  Many FSW endure violence from a 
multitude of sources, whether it be from paying clients or police.[1, 2, 8, 13, 48]  
Additionally, availability of condoms and other forms of HIV prevention or treatment are 
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particularly limited for FSW.[11, 31, 37]  At the interpersonal level, the FSW-client 
partnership dyads, FSW-stable partnership dyads, and gender norms influence the ability 
condom negotiation, the potential for intimate partner violence, and number of partners.[12, 
36, 42, 49-53]  The lack of social support networks for FSW precludes HIV prevention and 
treatment behaviors.[54-56]  FSW experience individual level barriers to care, including 
substance use and depression.[2, 4, 38]  Furthermore, biologically, FSW who have STI co-
infections are disproportionately at more risk for HIV, making is more challenging for 
remaining fully engaged in the HIV care continuum.[32, 43]  The specific multilevel barriers 
to engagement into HIV care and treatment, although well described in other high HIV 
prevalent settings, are poorly described for FSW in sub-Saharan Africa and must be 
identified to develop effective combination prevention and treatment interventions.   
Substance use among FSW 
Substance use is prevalent and likely an important barrier to engagement into the HIV 
care continuum among FSW in sub-Saharan Africa.  FSW have higher rates of substance use, 
including alcohol and marijuana, when compared to the general population due to their 
occupational and environmental factors.[4, 13]  In Malawi, nearly 45% of FSW report 
consuming 4 to 5 bottles of alcoholic beverages per day, which puts these women at great 
risk for alcohol dependency.[8, 41, 57]  Despite the recognition high prevalence of alcohol 
use among FSW, alcohol use among FSW are rarely systematically measured.[4, 58]  
Alcohol use is generally documented as lifetime use or general use, with studies rarely 
utilizing standardized and reliable screening tools, such as the Alcohol Use Disorder 
Identification Test (AUDIT), to assess the frequency and severity of alcohol use behaviors.  
The use of these validated tools can assist with the comparability of alcohol use studies 
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among FSW, in addition to more accurately examining the relationship between alcohol use 
and HIV care and treatment among FSW. 
The hazardous effects of alcohol use among HIV-infected individuals, not engaging 
in sex work, has been well documented.  Among the general population, alcohol use severely 
affects utilization of HIV care.[59-62]  The majority of longitudinal cohort studies have 
shown decreased ART adherence among HIV-infected individuals with alcohol use 
disorders.  However the measurement of alcohol use disorders substantially differed, by 
assessing heavy drinking, hazardous drinking or severe drinking.[60, 63, 64]  Additionally, 
the culmination of these results are further complicated by the differing measures of ART 
adherence: self-report, pill counts, or MEMS caps.  Even after accounting for HAART 
adherence, alcohol consumption is biologically associated with high viral load and other poor 
immunologic and virological outcomes.[65, 66]  Furthermore, hazardous drinking generally 
impairs cognitive functions and judgment, making it increasingly difficult to manage ART 
adherence and many other aspect of HIV care and treatment.[59, 61]  
Heavy use of marijuana, similar to alcohol, adversely affect decision-making, 
cognitive functions, and memory.[67, 68]  These adverse effects negatively likely negatively 
influence the necessary health seeking behavior for managing HIV care and treatment, 
including ART adherence.[69-71]  However, evidence is remains unclear if marijuana also 
precludes HIV specific health care utilization given the apparent lack of estimates of 
marijuana use.  Marijuana use estimates among FSW in Malawi are absent, nonetheless, 
marijuana is highly produced and a cheap form of intoxication.[24, 25, 72]  Substance use of 
both alcohol and marijuana are likely one major threat to improving linkage to HIV testing, 
care, and treatment among FSW. 
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Conceptual framework 
This dissertation is guided by self-regulation and coping theories that individuals 
engage in substance use to help cope with negative life events and dysregulate emotional 
states brought on by sex work, which in turn may influence HIV health seeking 
behaviors.[73-75]  We have developed a multidimensional conceptual model focused on the 
potential impact of alcohol and marijuana use on engagement in key HIV care continuum 
outcomes: HIV testing, ART initiation and ART adherence, and viral suppression among 
FSW (Figure 2.2).  The model depicts the influence of individual, social, and structural 
factors on each other, while simultaneously affecting alcohol and marijuana use among FSW.  
The factors in grey are unmeasured factors, while the factors in black were measured through 
this study.  For this dissertation, we explore the relationship between alcohol and marijuana 
use and engagement in HIV testing and treatment, while controlling for other measured 
individual, social, and structural factors.  We hypothesize that FSW who have a high levels 
of alcohol and marijuana use, will have less completion of the HIV care continuum compared 
to FSW who do not have high levels of alcohol and marijuana use. 
Preliminary studies 
In 2009, the UNC developed and implemented Priorities for Local AIDS Control 
Efforts (PLACE) in Lilongwe to assess key HIV transmission networks, including FSW, for 
the Ministry of Health.[76]  Of these, approximately 65% were bottle stores or bars/taverns 
and 23% were hotels, guest houses, or rest houses.  Among women (n=427) interviewed at 
these sites, 76% reported engaging in sex for pay in the past 4 weeks and 61% self-identified 
as a sex worker.  
The Family Planning Association of Malawi in 2011 conducted a situation analysis of 
the magnitude and behavioral patterns of FSW.[41]  An estimated 20,000 FSW work in 
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Malawi, with 3,500 FSW in Lilongwe. FSW were mostly 20-24 years old, found at bars, 
bottle stores, and guesthouses, and would take clients to nearby cars or rest houses.  Few 
problems were identified for enrolling FSW; however, the length of the survey had to be 
strongly considered as to not serve as a participation disincentive.  
In 2008, UNC Project assessed HIV prevalence in Malawi using multiple surveillance 
data sources.[77]  Among FSW, the HIV prevalence was 74%.  Only 10% of FSW reported 
condom use with their last sexual partner. About 70% of FSW reported ever being tested for 
HIV. In 2013, Theatre for a Change, a non-governmental organization and partners with 
UNC Project-Malawi, provided 1,213 FSW at approximately 25 different identified venues 
with health services in their mobile clinic.  Services included STI testing, family planning, 
psycho-social support, contraception and condoms.  These activities and the collaboration 
between UNC Project and Theatre for a Change demonstrate our ability to reach the FSW 
population in Lilongwe. Given the high burden of HIV infection, the FSW are clearly a key 
population for HIV prevention and treatment research. 
Key informant interviews were conducted with FSW community liaisons in 2014 by 
UNC Project assessed marijuana and alcohol prevalence among FSW in Lilongwe.  
Respondents agreed that both marijuana and alcohol use are common within Lilongwe and 
particularly among FSW.  Marijuana is considerably cheaper than alcohol and FSW often 
smoke marijuana in between clients while working or as a leisure activity when not working.  
In general, the respondents reported that FSW who engaged in alcohol consumption would 
also engage in marijuana use, yet, the patterns and frequency of using both marijuana and 
alcohol together have not been clearly delineated. 
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Innovation 
Acceptability, feasibility, and efficacy of HIV treatment as prevention strategies 
among FSW is unknown. ART significantly reduces HIV transmission among monogamous, 
serodiscordant couples through decreased viral load in genital secretions.[18]  The 
community-level effect of treatment as prevention is highly dependent on the success of 
identifying, linking to care, and initiating early ART among HIV-infected persons.[19, 20, 
78, 79]  However, FSW substantially differ from the predominately monogamous 
heterosexual couples of HPTN 052.[18]   
As previously mention, FSW tend to engage in high risk sexual behaviors, including 
– high rates of unprotected sex,[11, 31, 37, 38] anal sex,[39, 40] different sexual partners,[6, 
41] and concurrent sexual partners.[6, 32, 42]  Additionally, FSW have higher rates of STI 
co-infections.[32, 43]  The combination of these factors making FSW one of the hardest to 
reach populations for HIV care and treatment.  FSW have low levels of engagement into care 
and have the potential to transmit drug resistant HIV if adequate viral suppression is not 
achieved.[14, 21, 80, 81]  To maximize the benefits of treatment as prevention strategies, 
strategies to keep FSW engaged into the HIV care continuum must be identified.       
Understanding substance use’s influence on the HIV continuum of care will inform 
future treatment as prevention interventions for FSW.  FSW are an important contributor to 
HIV transmission, affecting the global HIV epidemic, making FSW in crucial need for 
“treatment as prevention” strategies.[19, 82]  Modeling shows that prioritizing treatment 
access to FSW could influence HIV transmission, if FSW are appropriately engaged into care 
and adhere to treatment.[19]  Given the negative effect of substance use on engagement in 
HIV care combined with a high prevalence of substance use among FSW, substance use 
could prevent the success of treatment as prevention interventions.  Successfully identifying 
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the impact of substance use on each point along the HIV care continuum will lead to future 
combination interventions that focus on substance use treatment and increasing access to 
HIV testing, care, and treatment among FSW. 
Actively identifying FSW in the field to provide rapid CD4 testing will facilitate 
immediate HIV care referral.  Approaches to streamline HIV services for FSW are 
imperative.  Rapid point-of-care CD4 testing has the great potential to improve immediate 
decision-making, patient management, and referral for hard-to-reach FSW.  The PIMA 
analyzer has been validated in several resource-limited settings to identify ART-
eligibility.[83-86]  When compared to a standard FACSCailbur platform the PIMA CD4 
counts had no significant difference.[84, 85]  The use of PIMA in mobile HIV testing and 
counseling settings in South Africa improved linkages to HIV care among HIV-infected 
individuals.[87]  Provision of CD4 testing in the field to FSW may alleviate testing burden 
not only for FSW, but also for centralized clinic-based laboratories.  To date, point-of-care 
CD4 has yet to be employed for FSW in the field. 
FSW will continue to disproportionately affect the global HIV epidemic, if left 
behind.  FSW will not benefit immunologically and clinically if they remain outside the HIV 
care continuum.[88, 89]  Furthermore, they may continue to transmit the virus and as 
mathematical modeling has shown, FSW significantly affect the HIV epidemic.[14, 19, 90]  
Increasing access to ART for FSW would have a significant effect on the HIV transmission 
in high HIV prevalent settings.  In 2013, the WHO’s recommended CD4 threshold for ART 
initiation increased to 500 cells/mm3.[91]  Theoretical models conducted in Kenya, reveal 
that expanding ART access to both FSW and their male clients who met the new WHO 
treatment guidelines could avert a third of new HIV infections among FSW and their clients 
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within the next decade.[92]  Directing HIV prevention efforts to FSW is an essential cost-
efficient use of already limited health systems and financial resources and additionally can 
dramatically reduce HIV transmission rates for all subpopulations.[93, 94]  However, this 
reduction is largely dependent on FSW receiving a timely diagnosis, engaging in care, 
adhering to ART, and retaining in HIV care. 
Summary 
Understanding the impact of alcohol and marijuana use has on the HIV care 
continuum among FSW will provide empirical evidence for developing and enhancing 
treatment as prevention strategies for FSW in sub-Saharan Africa.  The results from this 
study will have significant implications for the design of a combination intervention that 
focuses on substance use treatment and increasing access to HIV testing and treatment 
among FSW.  
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Figure 1. Barriers to engagement into the HIV care continuum among FSW 
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Figure 2. Conceptual framework for the impact of substance use on engagement in key HIV care continuum outcomes 
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CHAPTER III: RESEARCH DESIGN AND METHODS 
Study design overview 
To evaluate whether substance use, particularly alcohol and marijuana, significantly 
affects engagement in HIV testing and treatment among FSW, we conducted a cross-
sectional evaluation of FSW in Lilongwe, Malawi.  We used venue-based recruitment to 
recruit a sample of FSW.  All consented FSW participated in a face-to-face survey and 
received rapid HIV testing.  Among the seropositive FSW, we obtained CD4 cell counts and 
HIV-1 RNA levels.  We designed and implemented this study through a collaboration 
between The University of North Carolina at Chapel Hill, UNC Project Malawi, and Theatre 
for a Change, a non-governmental organization in Malawi. 
The research protocol, survey, and consent forms were reviewed and approved by the 
Institutional Review Board at the University of North Carolina and the Malawi Ministry of 
Health and Population National Health Sciences Research Committee (HSRC).  All 
participants provided written informed consent prior to completing study activities.  All study 
related activities were conducted in a safe and private location.    
Study setting 
Lilongwe is located in the Central Region of the Republic of Malawi (Figure 3.1).  
Nested within the district is Malawi’s administrative capital, Lilongwe City, with an 
estimated population of 1,346,360 persons.  The Malawian law does not explicitly 
criminalize sex work; however, “the keeping of brothels” and “living on the earnings of 
prostitution or influencing others to engage in prostitution” is illegal.[41]  Law enforcers 
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often perform night raids to arrest persons loitering in entertainment and public places, and 
FSW are most commonly arrested.[41]  To navigate the potential legal implications of 
working with FSW, community engagement activities were undertaken within the well-
established infrastructure of UNC Project-Malawi. 
UNC Project-Malawi provided an extensive research platform in Lilongwe, including 
a permanent research team, field workers, health care professionals, and an infrastructure that 
will support the implementation of this study.  For over twenty years, UNC and the Malawi 
Ministry of Health have collaborated on research, care, and training programs in Lilongwe.  
UNC Project-Malawi has a large, diverse and most importantly, active community advisory 
board (CAB).  The CAB is made up of participants in clinical trials, people living with HIV, 
and local community members, including traditional, civic, political, and religious 
community leaders.  
This study also reflected a partnership with the non-governmental organization, 
Theatre for a Change (TfaC).  Since 2003, TfaC has worked to empower women and girls 
and to develop programs focused on sex workers and their clients, sexually exploited 
children, pre-service and in-service teachers and primary school children.  TfaC has far-
reaching relationships with local stakeholders, including chiefs, police, NGOs, United 
Nations agencies and government ministries. 
UNC Project-Malawi provided the necessary infrastructure to navigate the complex 
and hard-to-reach FSW networks of Lilongwe.  UNC Project-Malawi was the optimal site for 
implementing our study.  
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Study procedures  
Pre-implementation activities 
In May 2014, prior to study recruitment, we held a stakeholder meeting with queen 
mothers in Lilongwe.  Queen mothers are mentor FSW who live at venues where FSW solicit 
sex.  At this meeting, 24 queen mothers attended, representing 23 different venues in 
Lilongwe.  During the stakeholder meeting, we informed the queen mothers about this study 
and its procedures.  We provided a forum for concerns to be raised and addressed.  Also, 
through UNC Project Malawi, our study was presented and discussed during the monthly 
community advisory board (CAB) meeting. 
Community mapping and venue identification 
From July 2014 through September 2014, we systematically recruited FSW using 
venue-based sampling.  Our outreach team comprised peer FSW, HIV testing counselors, 
interviewers, a study nurse, and male driver in a mobile clinic.  We developed the list of 
venues, in collaboration with Theatre for a Change and sex work stakeholders, where FSW 
are known to solicit sex. .  Brief face-to-face interviews were conducted with representatives 
or management from the identified venues to obtain characteristics of the venue, patrons, and 
alcohol availability.  Permission to recruit participants, in addition to commitment of 
ensuring safety of outreach team, was be obtained from venue management.  Brief face-to-
face interviews with people who are socializing at the venue were conducted to confirm 
whether or not FSW have solicited sex at the venue.    
Identification and recruitment of participants 
To systematically identify FSW, we used venue-based recruitment to identify FSW.  
These methods have documented success with identification of hidden populations, including 
FSW.[12, 95-98]  Women at a venue were approached by a member of our outreach team 
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and asked if they were willing to participate in screening for an HIV research study.  After 
verbal consent was obtained, women were brought to a confidential location outside received 
a brief screening survey to assess eligibility for participation.     
Selection criteria 
We used the 2011 Family Planning Association of Malawi’s definition of sex work, 
as someone “who had received money in exchange for sex either regularly or occasionally up 
to 12 months prior to the survey”.   
Inclusion criteria 
 Female age ≥18 years 
 Self identifies as someone who has received money in exchange for sex either 
regularly or occasionally up to 12 months prior to the date of the survey 
 Willingness to complete survey, undergo HIV testing and counseling and provide 
blood sample 
Exclusion criteria 
 Female <18 years 
 Male  
 Incapable of providing informed consent 
Informed consent 
If willing and eligible, FSW were asked to provide written informed consent for 
participation in the study.  The interviewer explained the purpose of the research study and 
criteria for participation.  During the informed consent process, the interview described the 
procedures the procedures, the risks and benefits of participation, the duration of 
participation, and the steps taken to protect confidentiality.  Participants provided their 
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signature on the consent form.  Non-literate participants were asked to document their 
understanding and consent with a mark (e.g., an X or thumbprint) in the presence of a literate 
third-party, impartial witness.  FSW participants who are non-literate chose a literate third-
party witness whom they feel comfortable disclosing their participation in the study.  Copies 
of the consent form were offered to the participants. 
Protection of human subjects 
The research protocol was reviewed by the Institutional Review Board at the 
University of North Carolina and the Malawi Ministry of Health and Population National 
Health Sciences Research Committee (HSRC).  All procedures conformed to U.S. and 
Malawian ethical standards for human subjects research.  This study received approval from 
the Institutional Review Board at the University of North Carolina on December 7, 2013 
(IRB#: 13-3283).  Approval from the HSRC was received on March 11, 2014 (Protocol#: 
1224). 
Data collection 
Consented FSW then received a face-to-face behavioral survey on substance use 
including alcohol and marijuana use, HIV testing history, HIV infection awareness, 
engagement in HIV care, and ART use.  We assessed HIV serostatus for all consented FSW.  
Per Malawian National HTC guidelines, FSW received serial HIV-antibody rapid tests, 
Determine HIV-1/2 and Uni-Gold rapid HIV-antibody.  Pre- and post-HIV test counseling, 
clinic referral, and risk reduction counseling was administered, and both male and female 
condoms were offered.   
For FSW with confirmed HIV infection, another finger stick was performed to collect 
blood for CD4 measurement and plasma HIV-1 RNA levels.  CD4 measurement was 
obtained using the Pima CD4TM, a self-contained, cartridge-based test platform with results 
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available in approximately 20 minutes.[84, 99]  The results were provided to the participant 
and a trained study nurse was available to assist the participant with interpretation of these 
results. 
Dried blood spots (DBS) were collected to determine HIV-1 RNA concentrations.  
DBS is an effective method for measuring plasma HIV-1 RNA levels.[100-102]  Samples 
were kept in drying boxing with a humidity indicator card to monitor moisture levels, until 
they were brought to the UNC Project laboratory.  HIV-1 RNA levels were available for 
women within 4 weeks of DBS collection and results were provided by a trained study nurse.   
Aim 1: Characterize the HIV care continuum among FSW in Lilongwe, Malawi 
HIV care continuum assessments 
HIV diagnosis:  We asked FSW to report the date and results of their most recent HIV 
test to determine new vs. previous diagnosis.  We defined a new HIV diagnosis as FSW who 
were seropositive, based HIV rapid testing, and self-reported being HIV negative at their 
most recent HIV test (or never testing previously).  We defined a previous diagnosis as those 
reporting being HIV-positive at their most recent test.   
History of HIV care:  For FSW who were self-reported being HIV-positive, we asked 
“Have you ever seen an HIV health care provider?”  FSW who responded yes to the question 
or reported current ART use were classified as having a history of HIV care.  All other FSW 
were classified as not having a history of HIV care. 
Current ART use: FSW who were previously diagnosed were asked the question “Are 
you currently on ART?”  Those who responded yes were defined as being on ART.  All other 
FSW were considered not on ART. 
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ART eligibility:  FSW were considered ART-eligible if they reported current ART 
use, had CD4 ≤500 cells/mm3 following the Malawi national guidelines, were currently 
pregnant or breastfeeding, or had a pregnancy after July 2011 following Option B+ policy.  
All other FSW were classified as ART-ineligible. 
ART adherence:  For the FSW who reported being on ART, we asked the question “In 
the last 4 weeks, when was the last time you missed taking any of your anti-HIV 
medications?” with the response options as: within the past week; 1-2 weeks ago; 2-4 weeks 
ago; or never skipped medications in the last 4 weeks.   
Viral suppression:  For all confirmed seropositive FSW, viral load was assessed.  We 
defined FSW as virally suppressed with an HIV-1 RNA ≤5000 copies/mL and defined as 
undetectable with an HIV-RNA ≤550 copies/mL, which are the recommended thresholds 
when using fingerstick DBS.[47, 103] 
Covariates 
We obtained data on demographic characteristics and sexual risk behaviors, which 
included: age (18-24, 25-29, ≥30 years),[104] years in sex work (<1, 1.0-1.9, 2.0-2.9, ≥3.0 
years),[105] weekly number clients (<10, 10-19, 20-29, ≥30 clients),[106] and condom use 
during vaginal sex with clients in prior 7 days (consistent use, inconsistent use).[106]   
Sensitivity analyses 
In addition to our primary analysis of the characterizing the HIV care continuum, we 
conducted two separate sensitivity analyses to address apparent discrepancies across key 
continuum indicators in a small number of FSW.  In the first sensitivity analysis, FSW who 
were virally suppressed but self-reported not previously diagnosed were re-assigned as 
seronegative to account for the possibility of false-positive HIV rapid tests.  In the second 
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sensitivity analysis, FSW who were virally suppressed but whose self-reports suggested they 
had not been previously diagnosed or did not report current ART use were re-assigned to 
categories in which they were assumed to be previously diagnosed, have a history of care, 
and be current ART users.  After we re-classified these FSW, we then re-calculated the key 
continuum outcomes and compared with our primary analysis. 
Aim 2: Evaluate and compare the associations of alcohol and marijuana use with lack of 
awareness of HIV infection 
 
Alcohol use assessment 
Alcohol use will be captured using the World Health Organization’s Alcohol Use 
Identification Test (AUDIT).[107-110]  The AUDIT measures alcohol use behaviors and 
alcohol use disorder symptoms (Table 3.1). The AUDIT is a screening tool for hazardous 
drinking, which is a pattern of drinking that poses high risk of future damage to physical or 
mental health.  This screening tool has been validated in various populations and has been 
widely used to screen for hazardous drinking in sub-Saharan Africa.[111, 112]  The AUDIT 
is a brief 10 question survey that consists of questions related to specific domains, like 
hazardous alcohol use, alcohol dependence symptoms, and harmful alcohol use.  Each of the 
10 questions has a set of responses with a corresponding score of 0 to 4.  Scores are added 
from each question resulting in one composite score ranging from 0 to 40.  A score of 8 or 
above indicates hazardous drinking, with an average sensitivity of the 90% and specificity of 
80% varying among populations and countries.  The WHO recommends shifting the cut-off 
for indication of hazardous drinking to a score of 7 to increase the sensitivity among 
women.[110]  Therefore, FSW with an AUDIT score of 7 will be indicative of hazardous 
drinking.   
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Marijuana use assessment 
Marijuana use was measured in terms of reported lifetime marijuana use and number 
of days using marijuana within the past 30 days (Table 3.2).  Current marijuana use was 
defined as at least one day of marijuana use within the prior 30 days.   
HIV history and infection assessments 
To measure HIV infection awareness, we asked FSW to report the results of their last 
HIV test.  FSW who were HIV-seropositive and self-reported themselves as HIV-negative 
from last HIV test, never receiving their results from an HIV test, or never previously tested 
for HIV were considered unware of HIV infection. 
Covariates 
We used directed acyclic graphs, based on the literature, to identify a minimally 
sufficient adjustment set of covariates to include in our analysis of the associations between 
alcohol and marijuana use, alone and together, with lack of HIV infection awareness.  
Covariates examined -included age (18-24, 25-29, ≥30 years), education (never attended 
school/only primary school, any secondary school/more school), marital status (never 
married, cohabitating/married, separated/divorced/widowed), housing (private house, bottle 
shop/bar, hotel/guesthouse), gravidity (no previous pregnancies, any previous pregnancies), 
financial dependents (no dependents, any dependents), probable depression measured by the 
Patient Health Questionnaire-9  (PHQ9 <10, PHQ9 ≥10),[113-115] and treatment for an STI 
in the prior 12 months (no, yes).  We also examined years in sex work (<1, 1.0-1.9, 2.0-2.9, 
≥3.0 years), location for soliciting paying sexual partners (bar/bottle shop, other), weekly 
number of clients (<10, 10-19, 20-29, ≥30 clients), condom use during vaginal sex with 
clients in prior 7 days (consistent use, inconsistent use),  ever had a client that demanded not 
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using a condom during vaginal sex (no, yes), alcohol use prior to last vaginal sex with client 
(no, yes), and any marijuana use prior to last vaginal sex with client (no, yes).  Categorization 
of the covariates were based on interpretability and replicability.   
Aim 3: Evaluate and compare the associations of alcohol and marijuana use with 
engagement into HIV treatment: current use of ART among ART eligible FSW and viral 
suppression 
 
Alcohol use assessment 
 Alcohol use was assessed as previously presented in aim 2. 
Marijuana use assessment 
 Marijuana use was assessed as previously presented in aim 2. 
HIV treatment assessments 
 We asked FSW to report the date and results of their most recent HIV test to 
determine new vs. previous diagnosis.  We defined a new HIV diagnosis as FSW who were 
seropositive, based HIV rapid testing, and self-reported being HIV negative at their most 
recent HIV test (or never testing previously).  We defined a previous diagnosis as those 
reporting being HIV-positive at their most recent test.   
We measured reported current ART use among all ART eligible FSW.  ART 
eligibility was defined as those reporting current ART use, a CD4 ≤500 cells/mm3 following 
the Malawi national guidelines, currently pregnant or breastfeeding, or any pregnancy after 
July 2011 following Option B+ policy.[116]  Option B+ provides confirmed HIV-infected 
pregnant and breastfeeding women lifelong ART regardless of CD4 count or clinical stage.  
FSW who answered no to the question “Are you currently on ART?” were defined as not 
using ART. 
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 We measured HIV-1 RNA concentration for viral suppression.  FSW were classified 
as virally nonsuppression with an HIV-1 RNA >5000 copies/mL which is the recommended 
thresholds when using fingerstick DBS.[47, 103]   
Covariates 
We used directed acyclic graphs, based on the literature, to identify minimally 
sufficient adjustment set of covariates to include in our models examining the associations 
between alcohol and marijuana use with sub-optimal HIV care and treatment outcomes.  The 
covariates we examined- included age (18-24, 25-29, ≥30 years), education (never attended 
school/only primary school, any secondary school/more school), marital status (never 
married, cohabitating/married, separated/divorced/widowed), housing (private house, bottle 
shop/bar, hotel/guesthouse), gravidity (no previous pregnancies, any previous pregnancies), 
financial dependents (no dependents, any dependents), probable depression measured by the 
Patient Health Questionnaire-9  (PHQ9 <10, PHQ9 ≥10),[113-115] and treated for an STI in 
the prior 12 months (no, yes).  We also examined years in sex work (<1, 1.0-1.9, 2.0-2.9, 
≥3.0 years), location for soliciting paying sexual partners (bar/bottle shop, other), weekly 
number clients (<10, 10-19, 20-29, ≥30 clients), condom use during vaginal sex with clients 
in prior 7 days (consistent use, inconsistent use),  paying sexual partner demanded not using 
a condom for vaginal sex (no, yes), and alcohol use prior to last vaginal sex with client (no, 
yes) Categorization of the covariates were based on interpretability and replicability.   
Data management and analysis 
Data management 
Data was derived from two source: face-to-face behavioral survey and laboratory 
data.  Survey data and laboratory results were entered using Open Data Kit Collect on an 
encrypted and password protected study android-based tablet by the principal investigator or 
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study staff.  All entered data was uploaded to the password-protected UNC Project shared 
server daily.  Data was housed at UNC Project-Malawi in Lilongwe, an HPTN/ACTG/MTN 
site, and the University of North Carolina at Chapel Hill.  All data collected underwent 
quality assurance and quality control testing adapted from HPTN/ACTG studies.  Study staff 
developed and implemented a system to track all questionnaires.  All FSW participants were 
assigned a unique study identification number that was used for this study.  Survey data and 
biological data were linked through this study identification number. 
Aim 1: Characterize the HIV care continuum among FSW in Lilongwe, Malawi 
Statistical analyses 
 We used frequency distributions and descriptive statistics to characterize the study 
population.  Proportions and associated 95% confidence intervals (CI) were computed for 
HIV serostatus and three key outcome of the HIV care continuum: history of HIV care, 
current ART use, and virally suppressed.  We characterized these continuum indicators using 
two different approaches.  The first approach is estimated using all HIV-infected FSW as the 
denominator, which provides information about opportunities for HIV transmission from 
FSW to their sexual partners. The second approach is estimated using the number of HIV-
infected FSW achieving the prior step in the continuum, which more directly highlights 
healthcare delivery gaps for HIV prevention and treatment services.  For example, within the 
second approach, the proportion of FSW who have a history of care has the denominator of 
FSW who reported being previously diagnosed.  In addition to these analyses of the three 
primary continuum outcomes (history of care, current ART use, and viral suppression), we 
also assessed ART use in relation to ART eligibility, and ART adherence among those on 
ART. 
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 We explored a demographic characteristics and transmission risk behaviors 
associated with HIV care continuum outcomes. A parsimonious set of demographic and 
transmission risk behaviors were established based on literature review and sample size 
considerations and included: age,[104] years in sex work,[105] weekly number clients,[106] 
and condom use during vaginal sex with clients in prior 7 days.[106]  The HIV care 
continuum outcomes assessed were a) previous diagnosis (vs. new diagnosis) among all 
HIV-infected FSW, b) history of HIV care (vs. no history of care) among those previously 
diagnosed, c) reported current ART use (vs. no current ART use) among those previously 
diagnosed and ART-eligible.  We examined associations using Poisson regression models 
with robust variance estimates to estimate prevalence ratios (PR) with 95% confidence 
intervals.[117]   
Aim 2: Evaluate and compare the associations of alcohol and marijuana use with lack of 
awareness of HIV infection 
 
Statistical analyses 
Characteristics, history of HIV testing, and substance use were summarized using 
frequencies and proportions for categorical variables and medians and interquartile ranges 
(IQR) for continuous variables.   
We conducted analyses for the associations of alcohol and marijuana use with the 
primary outcome of lack of HIV infection awareness.  We developed a product interaction 
term to assess the association between alcohol and marijuana use together and lack of HIV 
infection awareness.  We used Poisson regression with robust variance estimates to estimate 
bivariable and multivariable prevalence ratios (PR) with 95% confidence intervals (CI), due 
to problems with consistent convergence of log-binomial regression models.[118, 119]  The 
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prevalence ratio is the proportion of participants that have the outcome (D+) among exposed 
(E+) over the proportion of people that have the outcome (D+) among unexposed (E-). 
𝑃𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑅𝑎𝑡𝑖𝑜 =
𝑃(𝐷 +|𝐸+)
𝑃(𝐷 +|𝐸−)
 
Prevalence ratios are interpretable, less biased, and in comparison to odds ratios, the 
PR tends to be more consistent when estimating the total effect.[120-122]  In order to 
estimate the total effect of these associations, additional covariates were examined as 
possible confounders and effect measure modifiers.  
Potential confounders were assessed one-by-one, and retained in final adjusted 
multivariable models if removal resulted in a >10% change in the prevalence ratio estimate.  
Interactions were only considered for variables of interest that met positivity assumptions and 
were retained in the final adjusted multivariable models if they had public health relevance 
and reached statistical significance at alpha=0.10.  Collinearity was evaluated in the model 
using Pearson’s correlation coefficient; none of the covariates showed significant correlation 
(p-value ≥0.5).  
Aim 3: Evaluate and compare the associations of alcohol and marijuana use with 
engagement into HIV treatment: current use of ART among ART eligible FSW and viral 
suppression 
 
Statistical analyses 
We summarized the characteristics, substance use, and engagement in HIV treatment 
using frequencies and proportions for categorical variables and medians and interquartile 
ranges (IQR) for continuous variables. 
We conducted separate analyses for the associations of alcohol and marijuana use 
with the primary outcomes of lack of ART use and viral nonsuppression.  We used Poisson 
regression with robust variance estimates to estimate bivariable and, when sample size 
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permitted, multivariable prevalence ratios (PR) with 95% confidence intervals (CI).[118, 
119]   
We assessed potential confounders one-by-one, and retained in the final adjusted 
multivariable models if removal resulted in >10% change in estimate.  Interactions were only 
considered for variables of interest that met positivity assumptions and retained in final 
adjusted multivariable models if they reached statistical significance at alpha=0.10 and 
considered to have public health relevance.  Collinearity was evaluated in the model using 
Pearson’s correlation coefficient, though, none of the covariates showed significant 
correlation (p value ≥0.5).  
Limitations 
Specific limitations to each aim are incorporated within the discussions of chapters 4 
through 6.  Here we present certain limitations that applied to the implementation and design 
of all our aims. 
Challenges associated with recruiting FSW   
During the community mapping activities, we engaged with venue owners to inform 
them that we were conducting a substance use and sexual health study among women 
patrons.  We alleviated any resistance owners had by study staff showing up announced.  We 
were also aware of the difficulties identifying FSW and subsequently obtaining their consent 
to participate in the survey while they were working.  The duration of the survey was kept 
manageable, as not to serve as a disincentive for participation.  We also conveyed the 
benefits of receiving HIV testing on site, particularly among FSW who are unaware of their 
infection, and CD4 cell counts among HIV infected FSW not on ART. 
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Self-report of substance use 
The measure of substance use was based on self-report. Given the need for social 
acceptance, this measurement may be susceptible to social desirability bias and recall bias.  
We incorporated strategies in survey administration to minimize these potential biases, such 
as the use of trained interviewers, building rapport, and reassuring confidentiality throughout 
the survey. 
Generalizability of results  
All FSW who are enrolled in this study were enrolled at venues where they were be 
soliciting clients.  Therefore, street-based FSW were likely not included in our sample.  
These FSW may fundamentally be different than those in our study, in terms of their HIV 
risk structure and health seeking behaviors.  We made sure that our results did not 
inappropriately generalize FSW outside of our study sample.  
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  Figure 3. Map of Lilongwe, Malawi 
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Table 1. Measurement of alcohol use 
Question Response (score) 
Alcohol Use Disorder Identification Test (AUDIT) 
Composite score  
How often do you have a drink containing alcohol? Never (0) 
Once a month or less (1) 
2 to 4 times a month (2) 
2 to 3 times a week (3) 
4 times or more a week (4) 
How many drinks containing alcohol do you have on 
a typical day when you are drinking? 
1 or 2 drinks (0) 
3 or 4 drinks (1) 
5 or 6 drinks (2) 
7, 8, or 9 drinks (3) 
10 or more drinks (4) 
How often do you have six or more drinks on one 
occasion? 
Never (0) 
Less than monthly (1) 
Monthly (2) 
Weekly (3) 
Daily or almost daily (4) 
How often during the last year have you found that 
you were not able to stop drinking once you had 
started? 
Never (0) 
Less than monthly (1) 
Monthly (2) 
Weekly (3) 
Daily or almost daily (4) 
How often during the last year have you failed to do 
what was normally expected from you because of 
drinking? 
Never (0) 
Less than monthly (1) 
Monthly (2) 
Weekly (3) 
Daily or almost daily (4) 
How often during the last year have you needed a 
first drink in the morning to get yourself going after a 
heavy drinking session? 
Never (0) 
Less than monthly (1) 
Monthly (2) 
Weekly (3) 
Daily or almost daily (4) 
How often during the last year have you had a feeling 
of guilt or remorse after drinking? 
Never (0) 
Less than monthly (1) 
Monthly (2) 
Weekly (3) 
Daily or almost daily (4) 
How often during the last year have you been unable 
to remember what happened the night before because 
you had been drinking? 
Never (0) 
Less than monthly (1) 
Monthly (2) 
Weekly (3) 
Daily or almost daily (4) 
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Have you or someone else been injured as a result of 
your drinking? 
No (0) 
Yes, but no in the last year (2) 
Yes, during the last year (4) 
Has a relative, friend, or a doctor or other health 
worker been concerned about your drinking or 
suggested that you cut down on your drinking? 
No (0) 
Yes, but no in the last year (2) 
Yes, during the last year (4) 
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Table 2. Measurement of marijuana use 
Question Response 
Marijuana use 
Have you ever used marijuana? Yes 
No 
In the past 30 days, how many days have you used 
marijuana? 
0 – 30 days 
On the days that you used marijuana on about how 
many times did you use marijuana per day? 
0 – 30 times 
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CHAPTER IV: THE HIV CARE CONTINUUM AMONG FEMALE SEX WORKERS, 
A KEY POPULATION IN LILONGWE, MALAWI 
INTRODUCTION 
HIV prevalence among female sex workers (FSW) remains disproportionately high 
despite decades of prevention activities.[29-34]  Globally, the HIV prevalence among FSW is 
12%, with a higher prevalence of 37% in sub-Saharan Africa.  HIV-infected FSW have a 
higher number of sexual partners compared to other women of reproductive age, increasing 
the likelihood of HIV acquisition, as well as transmission to their clients and onward 
transmission from clients to other sexual partners.[30, 123]  Effective interventions are 
clearly needed to reduce HIV acquisition and transmission from this key population.   
Anti-retroviral therapy (ART) sharply reduces HIV morbidity, mortality, and 
transmission.[18, 124] To experience these benefits of ART, HIV-infected persons must be 
diagnosed and receive HIV care and treatment.  The HIV care continuum is a commonly 
used framework that provides cross-sectional descriptions of population-level engagement in 
HIV testing, care, and treatment. [12, 20]  If HIV-infected FSW fail to attain optimal 
outcomes along this “HIV continuum,” they will not receive the clinical benefits of HIV care 
and treatment, and also will likely continue to transmit HIV.[19, 125]    
The HIV care continuum has not been well characterized in FSW.[125, 126]  
Estimates of ART initiation, adherence, and treatment outcomes among this key population 
in sub-Saharan have been derived predominately from small, intensively followed cohorts 
whose experiences may not be representative of FSW more generally.[126]  Without 
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estimates of engagement in HIV care and treatment among FSW outside of these intensively 
followed cohorts, the unmet needs of this population are difficult to assess.   
We conducted the first study to characterize the HIV care continuum among FSW in 
Lilongwe, Malawi, where the FSW HIV prevalence (70%) is one of the highest globally.[30]  
In addition to quantifying the continuum, we examined the associations between continuum 
outcomes and both demographic characteristics and transmission risk behaviors.   
METHODS 
Study procedures 
We designed and implemented this study through a collaboration between The 
University of North Carolina at Chapel Hill, UNC Project Malawi, and Theatre for a Change 
(TfaC), a non-governmental organization in Malawi with far-reaching relationships with 
local sex work stakeholders including FSW, chiefs, police, local NGOs, and Malawian 
government ministries.  This study is a descriptive, cross-sectional biological and behavioral 
survey among FSW in Lilongwe, Malawi.  FSW were systematically recruited using venue-
based sampling.  Venue-based sampling has documented success with identification of 
hidden populations, including FSW.[12, 95-98]  Our reach team comprised of HIV testing 
counselors, interviewers, a study nurse, male driver for the mobile clinic, and a peer FSW to 
facilitate approaching women at the venues.  In collaboration with TfaC, we developed the 
list of venues where FSW are known to solicit sex. 
From July through September 2014, FSW were recruited from 23 different venues 
within Lilongwe; most venues were bars and bottle shops.  Women at a venue were 
approached by a member of our outreach team and asked if they would like to participate in a 
research study for FSW.  We used the 2011 Family Planning Association of Malawi’s 
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definition of sex work, as someone “who had received money in exchange for sex either 
regularly or occasionally up to 12 months prior to the survey”.  Women were eligible for 
enrollment if they were at least 18 years of age and self-reported as a FSW.  All FSW 
provided written informed consent. 
All consenting FSW completed a structured behavioral survey to obtain detailed 
information on demographics, pregnancy history, transmission risk behaviors, HIV testing 
history, and engagement in HIV care and treatment.  The survey was translated from English 
to Chichewa, the predominant language in Malawi, and back translated.  The survey was 
available in both languages to all FSW.   
HIV serostatus was confirmed for all participating FSW using Malawian National 
HIV Testing and Counseling guidelines, which indicate serial HIV-antibody rapid tests, 
Determine HIV-1/2 and Uni-Gold rapid HIV-antibody.  Pre- and post-HIV test counseling, 
clinic referral, and risk reduction counseling were administered, and both male and female 
condoms were offered.  FSW were defined as HIV seronegative with a negative Determine 
HIV-1/2 test result or HIV seropositive with positive Determine HIV-1/2 and Uni-Gold test 
results.   
For FSW with confirmed HIV infection, another finger stick was performed to collect 
blood for CD4 measurement and plasma HIV-1 RNA levels.  CD4 measurement was 
obtained using the Pima CD4TM, a self-contained, cartridge-based test platform with results 
available in approximately 20 minutes.[84, 99]  The results were provided to the participant 
and a trained study nurse was available to assist the participant with interpretation of these 
results. 
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Dried blood spot (DBS) were collected to determine HIV-1 RNA 
concentrations.[100-102]  Samples were kept in drying boxing with a humidity indicator card 
to monitor moisture levels, until they were brought to the UNC Project laboratory.  HIV-1 
RNA levels were available for within 4 weeks of DBS collection and results were provided 
by a trained study nurse.   
All FSW confirmed HIV seropositive were referred to Lighthouse Trust HIV Clinic 
in Lilongwe for medical care and treatment.  All study-related activities were conducted in a 
safe and private location.   
Data collection 
To assess whether women testing positive were newly (vs. previously) diagnosed, 
FSW were asked to report the date and results of their most recent HIV test.  FSW who were 
seropositive and self-reported being HIV negative at their most recent HIV test (or never 
testing previously) were defined as a new HIV diagnosis; those reporting being HIV-positive 
at their most recent test were classified as previously diagnosed.  Previously diagnosed FSW 
who responded yes to the question “Have you ever seen an HIV health care provider?” or 
reported current ART use were classified as having history of HIV care.  Previously 
diagnosed FSW who answered yes to the question “Are you currently on ART?”  were 
classified as being on ART. ART-eligible FSW were defined as those reporting current ART 
use, a CD4 ≤500 cells/mm3  following the Malawi national guidelines, currently pregnant or 
breastfeeding, or any pregnancy after July 2011 following Option B+ policy.[116]  The 
Option B+ policy provides confirmed HIV-infected pregnant and breastfeeding women 
lifelong ART regardless of CD4 count or clinical stage.   ART adherence was assessed based 
on responses to the question “In the last 4 weeks, when was the last time you missed taking 
any of your anti-HIV medications?” (within the past week; 1-2 weeks ago; 2-4 weeks ago; or 
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never skipped medications in the last 4 weeks).  All HIV-infected FSW provided blood 
specimens for HIV-1 RNA levels.  FSW were defined as virally suppressed with an HIV-1 
RNA ≤5000 copies/mL and defined as undetectable with an HIV-RNA ≤550 copies/mL, the 
recommended thresholds when using fingerstick DBS.[47, 103]   
Data analyses 
 We used frequency distributions and descriptive statistics to characterize the study 
population.  Proportions and associated 95% confidence intervals (CI) were computed for 
HIV serostatus and three key outcome of the HIV care continuum: history of HIV care, 
current ART use, and virally suppressed.  We characterized these continuum indicators using 
two different approaches.  The first approach, which provides information about 
opportunities for HIV transmission from FSW to their sexual partners, is estimated using all 
HIV-infected FSW as the denominator. The second approach, which more directly highlights 
healthcare delivery gaps for HIV prevention and treatment services, is estimated using the 
number of HIV-infected FSW achieving the prior step in the continuum.  For example, under 
the second approach, the proportion of FSW who have a history of care has the denominator 
of FSW who reported being previously diagnosed.  We report separately the small proportion 
of discrepancies across the three key continuum outcomes. In addition to these analyses of 
the three primary continuum outcomes, we also assessed ART use in relation to ART 
eligibility, and ART adherence among those on ART.   
 Demographic characteristics and transmission risk behaviors associated with HIV 
care continuum outcomes were explored. A parsimonious set of demographic and 
transmission risk behaviors were established based on literature review and sample size 
considerations, which included: age (18-24, 25-29, ≥30 years),[104] years in sex work (<1, 
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1.0-1.9, 2.0-2.9, ≥3.0 years),[105] weekly number clients (≤19, ≥20 clients),[106] and 
condom use during vaginal sex with clients in prior 7 days (consistent use, inconsistent 
use).[106]  The question used to assess condom use was “How often did you use condoms 
during vaginal sex with a paying sexual client in the last 7 days?”  Reponses included never, 
rarely, sometimes, most times, and always.  FSW who responded always were classified as 
having consistent use and all other responses were classified having inconsistent use.  The 
three key HIV care continuum outcomes assessed were a) previous diagnosis (vs. new 
diagnosis) among all HIV-infected FSW, b) history of HIV care (vs. no history of care) 
among those previously diagnosed, c) reported current ART use (vs. no current ART use) 
among those previously diagnosed and ART-eligible.  We examined associations using 
Poisson regression models with robust variance estimates to estimate prevalence ratios (PR) 
with 95% confidence intervals.[117]   
Sensitivity Analyses  
 We conducted two sensitivity analyses to address apparent discrepancies across key 
continuum indicators in a small number of FSW.  First, FSW who were virally suppressed 
but self-reported not previously diagnosed were re-assigned as seronegative to account for 
the possibility of false-positive HIV rapid tests.  Second, FSW who were virally suppressed 
but whose self-reports suggested they had not been previously diagnosed or did not report 
current ART use were re-assigned to categories in which they were assumed to be previously 
diagnosed, have a history of care, and be current ART users.  Following re-classifications of 
these FSW, we re-calculated the key continuum outcomes. 
All statistical analyses were conducted using SAS software version 9.3 (SAS Institute, Cary, 
NC, USA). 
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Ethics Statement 
Ethics approval was obtained from the Malawi Ministry of Health and Population 
National Health Sciences Research Committee (HSRC) and the University of North 
Carolina-Chapel Hill Institutional Review Board. 
RESULTS 
Among the total study population (n=200), the median age was 24 years (IQR: 22-
28).  Most (66%) had not completed primary school and the majority (81%) were separated, 
divorced, or widowed (Table 1).  Approximately 60% reported currently living in a bar or 
bottle shop, and 90% solicited clients at these venues.  The median duration of exchanging 
sex for money was 3 years (IQR: 1-5).  The median reported number of clients in the past 7 
days was 21 (IQR: 10-35).  Nearly three quarters reported consistent condom use during 
vaginal sex with clients in the past 7 days.       
HIV diagnosis 
The HIV seroprevalence was very high (69%, 95% CI: 62, 75%, n=138).  Among the 
HIV-infected FSW, 20% (95% CI: 13, 26%, n=27) were newly diagnosed (Table 2); of these, 
74% (95% CI: 54, 89%, n=20) had tested negative previously, 19% (95% CI: 6, 38%, n=5) 
had never tested, and 7% (95% CI: 1, 24%, n=2) had tested but not received results (results 
not shown).  Among newly diagnosed FSW that had previously tested negative, the median 
time since last HIV test was 11 months (IQR: 3-17).  The median CD4 among all newly 
diagnosed FSW was 464 cells/mm3 (IQR: 276-632) and median viral load was 44, 846 
copies/ml (IQR: 5,981- 202,395).  Among previously diagnosed HIV-infected FSW, median 
time since diagnosis was 14 months (IQR: 4-44). The median CD4 was 528 cells/mm3 (IQR: 
355-747).     
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History of HIV care 
Among all HIV-infected FSW, 69% (95% CI: 61, 76%, n=95) had a history of HIV 
care, as determined by report of ever seeing an HIV care provider or current ART use (Figure 
1A).  Among FSW previously diagnosed, 86% (95% CI: 78, 92%, n=95) had a history of 
HIV care (Figure 1B). 
Current ART use 
Among the 52% (95% CI: 44, 61%, n=72) of all HIV-infected FSW who were 
currently on ART (Figure 1A), adherence was suboptimal: 33% (95% CI: 23, 45%) reported 
skipping pills within the past 4 weeks (results not shown).  Three fourths (76%, 95% CI: 66, 
84%, n=72) of FSW previously diagnosed with a history of care reported current ART use 
(Figure 1B). 
About half of all HIV-infected FSW (48%; 95% CI: 35, 56%, n=66) reported no 
current ART use; their median CD4 was 478 cells/mm3 (IQR: 321-656).  Of those that 
reported no current ART use, 62% (95% CI: %, n=41) were eligible for ART, with 42% 
(95% CI: 26, 58%, n=17) newly diagnosed and 59% (95% CI: 42, 74%, n=24) previously 
diagnosed.  Among the previously diagnosed with no current ART use and ART eligible 
(n=24), 92% (95% CI: 73, 99%, n=22) had a CD4 ≤500 cells/mm3 with an additional 8% 
(95% CI: 1, 27%, n=2) that were ART-eligible based on Option B+ (currently pregnant, 
currently breastfeeding, or any pregnancy after July 2011). 
Viral suppression 
Approximately half (45%, 95% CI: 36, 54%, n=62) (Figure 1A) of all HIV-infected 
FSW were virally suppressed (≤5000 copies/mL) and 38% had an undetectable viral load 
(≤550 copies/mL).  Among previously diagnosed FSW (n=111), half had undetectable viral 
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loads (median viral load= 0 copies/ml IQR: 0- 31,295) (Table 2).  Of the FSW who reported 
current ART use, 86% (95% CI: 76, 93%, n=62) had viral loads ≤5000 copies/mL (Figure 
1B).  Seven women (5%) of all HIV-infected FSW were identified as virally suppressed but 
did not report current ART use or previous HIV diagnosis.   
Sensitivity analyses 
Among the seven FSW who were virally suppressed but did not report experience 
with “upstream” continuum indicators, four reported previous diagnosis and a history of care 
but no current ART use, and three had no indication of previous diagnosis, history of care, or 
current ART use based on self-report.   
In the first sensitivity analysis that re-classified the three FSW that self-reported not 
being previously diagnosed as seronegative, the HIV seroprevalence was similar to the 
seroprevalence of the primary analyses.  Of all the 200 FSW enrolled in our study, 68% were 
seropositive (95% CI: 61, 74%).     
In the second sensitivity analysis that re-classified these seven FSW as being 
previously diagnosed, with a history of care and current ART use, the overall proportions 
achieving the HIV care continuum outcomes were similar to those obtained in the main 
analyses.  Of all HIV-infected FSW, 72% (95% CI: 64, 80%) had a history of care, 57% 
(95% CI: 49, 66%) reported current ART use, and 50% (95% CI: 41, 59%) were virally 
suppressed.  Among previously diagnosed FSW (83%, (95% CI: 75, 89%), 88% (95% CI: 
80, 93%) had a history of care.  Of those with a history of care, 79% (95% CI: 70, 87%) FSW 
currently ART using and among those with current ART use, 87% (95% CI: 78, 94%) were 
virally suppressed.     
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Factors associated with HIV care continuum outcomes 
In multivariable analyses (Table 3), there was little to no association between age, 
duration in sex work, number of weekly clients and condom use and the key HIV care 
continuum outcomes: previously diagnosed, history of HIV care, and current ART use.   
FSW who were younger (18-24 years: APR: 0.74, 95% CI: 0.30, 1.84; 25-29 years: 
APR: 0.84, 95% CI: 0.34, 1.91) and reported ≤19 clients per week (APR: 0.67, 95% CI: 0.33, 
1.36) were less likely to be previously (vs. newly) diagnosed.  FSW who were engaged in sex 
work for <1.0 year (APR: 1.81, 95% CI: 0.62, 5.33) or 1.0-1.9 years (APR: 2.04, 95% CI: 
0.85, 4.94) were more likely to be previously diagnosed.  FSW who reported inconsistent 
condom use with clients in the prior 7 days were 1.65 (95% CI: 0.70, 3.47) times as likely to 
be previously diagnosed when compared to FSW who reported consistent condom use.   
FSW who were 25-29 years were 0.89 (95% CI: 0.73, 1.14) times as likely to have a 
history of care (vs. no history of care) than FSW who were ≥30 years old.  FSW that were 
engaged in sex work for 1.0-1.9 years (APR: 0.84, 95% CI: 0.463, 1.12) and reported 
inconsistent condom use (APR: 0.90, 95% CI: 0.75, 1.01) were less likely to have a history 
of HIV care.  FSW who reported ≤19 clients per week were 1.12 (95% CI: 0.96, 1.30) times 
as likely to have a history of care compared to FSW who reported ≥20 clients per week.   
FSW who were younger and engaged in sex work for less than 3 years were less 
likely to have current ART use when compared to FSW who were ≥30 years old and engaged 
in sex work for ≥3 years.  FSW who reported ≤19 clients per week were 1.10 (95% CI: 0.88, 
1.38) times as likely to have a history of care compared to FSW who reported ≥20 clients per 
week.  FSW who reported inconsistent condom use with clients in the prior 7 days were 1.08 
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(95% CI: 0.84, 1.38) times as likely to be previously diagnosed when compared to FSW who 
reported consistent condom use.       
DISCUSSION 
In this study, FSW in Lilongwe, Malawi were heavily HIV burdened, with one-fifth 
of HIV-infected FSW being previously unaware of their HIV infection.  Although most HIV-
infected FSW reported seeing an HIV healthcare provider at least once, only half reported 
current ART use.  More encouragingly, among FSW on ART, over four-fifths were virally 
suppressed, the ultimate goal for clinical and transmission outcomes.  Both HIV-infected and 
HIV-uninfected FSW in our sample were highly active and engaging in high-risk sexual 
behaviors.  Among HIV-infected FSW, transmission risk behaviors were not statistically 
associated with being previously diagnosed, having a history of HIV care, or current use of 
ART.   
Despite continued HIV prevention efforts in Malawi, the HIV seroprevalence among 
this sample of FSW in Lilongwe remains consistent with estimates from nearly a decade ago.  
The 2006 bio-behavioral surveillance survey among 273 FSW from six urban centers of 
Malawi, including Lilongwe, identified 71% of FSW as HIV-infected.[127]  We expected the 
FSW prevalence to have  fallen along with the national HIV prevalence.[127]  Malawi’s 
adult HIV prevalence has steadily declined from its peak of 18% in 2000 to 11% in 2010 
among adults, including 13% among adult women.[128]  Our prevalence may be an 
overestimate for all FSW in Malawi, given all the FSW were recruited within venues in 
Lilongwe, the capital and second largest city in Malawi. However, current national HIV 
prevalence estimates among FSW are unavailable for comparison.  The consistently high 
HIV prevalence among FSW in Malawi over the past decade highlights the importance of 
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combination behavioral, biomedical, and structural HIV prevention and treatment efforts for 
both HIV-uninfected and infected FSW.   
The proportion of FSW newly diagnosed, as part of our study, has serious 
consequences for both FSW and their sexual partners.  Establishing a timely HIV diagnosis 
for highly active FSW is absolutely critical.[129]  FSW who remain unaware of their HIV 
infection miss opportunities for entry into HIV care, leading to later ART initiation, higher 
risk for HIV clinical progression, and ongoing transmission.[130]  The time between tests 
identified in our study highlights the need for frequent outreach to encourage rapid HIV 
testing to capture highly active FSW at most risk for ongoing HIV transmission. 
Overall in this sample, about half of HIV-infected FSW were not on ART and 
therefore not receiving the full clinical, immunological, and transmission prevention benefits 
of therapy.  Despite the recognition that timely uptake of ART can improve health outcomes 
and decrease onward transmission,[14-16] there are currently no interventions specifically 
focusing on increased access and adherence to ART for FSW in sub-Saharan Africa.[14]  
However, the recent expansions of ART may increase ART initiation among FSW.  Since 
2011, Malawi has provided lifelong ART for all women who are pregnant or breastfeeding 
for the prevention of mother-to-child transmission under Option B+.[29]  In addition to 
Option B+, Malawi has implemented earlier initiation of ART (CD4 count ≤500 cells/mm3) 
in April 2014.[131]  Further expansion of ART initiation should be prioritized to reach all 
HIV-infected FSW in Malawi. 
FSW face a complex lattice of individual, social, and structural barriers to HIV care 
and ART uptake with the goal for viral suppression.  For example, FSW are highly 
stigmatized, experiencing discrimination and violence, which can have damaging effects on 
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access to HIV care and treatment.[11, 36, 132]  Furthermore, FSW often use alcohol as a 
means to facilitate sex work.[4]  This high-risk alcohol consumption impairs judgment and 
cognitive function, making it even more challenging for FSW to access care and initiate 
ART.[59, 61]  The specific barriers affecting ART uptake among FSW in sub-Saharan Africa 
are poorly described.  Successfully identifying the impact of these barriers on ART uptake in 
sub-Saharan Africa, including Malawi, can inform tailored multilevel combination 
interventions focused on increasing access and uptake of ART, and ultimately viral 
suppression, for HIV-infected FSW. 
Within our sample of FSW, we identified little to no association between 
transmission risk behaviors and key HIV care continuum outcomes.  These results are in 
contrast to observed reductions in sexual risk behaviors following HIV diagnosis,[133] 
initiation of HIV care and treatment among non-FSW populations.[134-136]  The null 
association between behaviors and continuum outcomes in our FSW population may be due 
to the nature of their work: because their livelihoods depend on high-risk sexual behaviors, 
FSW may face greater difficulty in reducing transmission risk behaviors following diagnosis 
and engagement in care than do other populations.[30]   
Another important unmet need identified in the study is prevention for HIV-
uninfected FSW.  HIV-uninfected FSW within our sample are at increased risk for HIV 
acquisition due to their numerous weekly clients and inconsistent condom use and are in need 
of a tailored comprehensive package of interventions.  Pre-exposure prophylaxis (PrEP) has 
emerged as an effective biomedical intervention to prevent HIV infection.[137]  Although it 
has not yet been evaluated specifically among FSW, PrEP could provide a highly effective 
prevention strategy for at risk FSW.  Given the multilevel HIV risks FSW face, PrEP must be 
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complemented with other proven effective interventions, such as community empowerment 
and testing and treatment strategies to reduce HIV incidence in FSW and their clients.[138]  
Comprehensive prevention packages that incorporate PrEP delivery must be developed and 
rigorously evaluated among FSW. 
In this study, the HIV care continuum provided a valuable framework for describing 
HIV testing, care, and treatment cross-sectionally among FSW in Lilongwe, Malawi; 
however, the framework fails to fully capture the dynamic nature of FSW’s engagement in 
the trade and with HIV prevention and care services.  For example, the traditional continuum 
framework does not explicitly describe important processes, such as care re-engagement and 
viral re-suppression that may occur for some HIV-infected FSW.[126]  A related limitation is 
that we assessed HIV care history but not current HIV care status; therefore, we were unable 
to determine whether suboptimal ART use among ART-eligible FSW was due to care dis-
engagement or rather failures in ART initiation/re-initiation among FSW who were currently 
in care. Prospective, longitudinal studies that can better enumerate dynamic, multidirectional 
movement would provide additional, useful understanding of HIV testing, care, and 
treatment of FSW.            
        The outcomes we used to describe the HIV care continuum were mostly reliant on 
self-report and thus subject to misclassification.  In particular, our estimated proportion of 
newly diagnosed FSW may be an overestimate of new diagnoses if women were 
uncomfortable reporting their known HIV-positive status.  Additionally, FSW who were 
previously diagnosed but not on ART may have felt it more socially desirable to report not 
being previously diagnosed and therefore unable to be on ART.  Furthermore, FSW who 
were virally suppressed but did not report engaging in “upstream” care continuum outcomes 
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may have been concerned about reporting HIV status awareness while continuing to be 
engaged in sex work.  This apparent discrepancy related to virally suppressed FSW that are 
reportedly unengaged in HIV care and not on ART, which may be partially explained by the 
possibility that some small percentage were elite controllers,[139] has been seen previously 
among FSW in Zimbabwe.[140]  Clinical records could potentially have provided more 
reliable diagnosis and ART use data; however, such data are not readily available in Malawi.                 
This study was the first to characterize key HIV care continuum outcomes among a 
sample of FSW in Lilongwe, Malawi—where the HIV prevalence among FSW remains 
among the highest globally.  HIV-burdened FSW in sub-Saharan Africa are severely 
understudied and underserved, leading to limited understanding of and attention to their HIV 
testing, care, and treatment engagement.  Our study suggests an enormous need for integrated 
behavioral, biomedical, and structural approaches for both HIV-infected and HIV-uninfected 
FSW to improve clinical outcomes and prevent onward transmission.    
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Table 3. Characteristics of female sex workers in Lilongwe, Malawi, July-September 2014 
 Total 
Population 
(n=200) 
HIV 
seronegative 
(n=62) 
HIV 
 seropositive  
(n=138) 
 n (%) n (%) n (%) 
Age (years)       
     18-24 101 (51) 44 (71) 57 (41) 
     25-29 54 (27) 10 (16) 44 (32) 
     ≥30 45 (22) 8 (13) 37 (27) 
Nationality       
     Malawian 195 (98) 62 (100) 133 (96) 
     Other 5 (2) 0 (0) 5 (4) 
Education       
Never attended school 15 (7) 5  (8) 10 (7) 
Some primary 117 (59) 36 (58) 81 (59) 
Completed primary 20 (10) 3 (5) 17 (12) 
     Some secondary 44 (22) 15 (24) 29 (21) 
     Completed primary 4 (2) 3 (5) 1 (1) 
Marital status*       
Never married 28 (14) 13  (21) 15 (11) 
Married (legal or traditional) 
or co-habitating 
9 (4) 3 (5) 6 (4) 
Separated, divorced, or 
widowed 
162 (81) 45  (73) 117 (85) 
Housing       
Private house 27 (13) 10 (16) 17 (12) 
Bar or Bottle shop 115 (58) 35 (57) 80 (58) 
Guesthouse or hotel 58 (29) 17 (27) 41 (30) 
Number of pregnancies       
     0 15 (7) 4 (6) 11 (8) 
     1 56 (28) 19 (31) 37 (27) 
     ≥2 129 (65) 39 (63) 90 (65) 
Duration of sex work (years)*       
     <1.0 25 (12) 10 (16) 15 (11) 
     1.0-1.9 39 (20) 15 (24) 24 (17) 
     2.0-2.9 34 (17) 12 (19) 22 (16) 
     ≥3.0 100 (50) 23 (37) 77 (56) 
Location for soliciting clients       
     Bar or bottle shop 181 (91) 57 (92) 124 (90) 
     Other 19 (9) 5 (8) 14 (10) 
Number of clients per week*       
     <10 43 (21) 16 (27) 27 (20) 
     10-19 45 (23) 12 (19) 33 (24) 
     20-29 52 (26) 19 (31) 33 (24) 
     ≥30 58 (29) 14 (23) 44 (32) 
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Condom use with paying sexual 
partners in past 7 days† 
      
Inconsistent 49 (24) 13 (21) 36 (26) 
Consistent 151 (76) 49 (79) 102 (74) 
*Missing data due to not knowing or refused to answer: marital status: n=1; number of years exchanging sex for money: 
n=2; number of paying sexual partners in past 7 days: n=2  
†
Inconsistent includes FSW who responded “never”, “rarely”, “sometimes”, or “most times”; Consistent includes FSW who 
responded “always”. 
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Table 4. HIV testing history, CD4 count, and VL at the time of cross-sectional survey by new 
and previous HIV diagnosis for female sex workers, (n=138) 
 New HIV diagnosis  
(n=27) 
Previous HIV 
diagnosis 
(n=111) 
 Median (Interquartile Range) 
Time since last HIV test (months)* 11 (3-17) 14 (4-44) 
CD4 count, cells/mm3 464 (276-632) 528 (355-747) 
Viral load, copies/ml 44, 846 (5,981- 202,395) 0 (0- 31,295) 
*Among those who report previously testing negative 
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Figure 4. HIV Care Continuum among HIV-infected female sex workers, Lilongwe, Malawi (n=138). A) Among all HIV-infected 
FSW; B) Among FSW achieving prior step. 
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Table 5. Associations of demographic and transmission risk behaviors with HIV care continuum outcomes (previously HIV 
diagnosed, history of HIV care, and current ART use) among HIV-infected female sex workers in Lilongwe, Malawi 
 Previously HIV diagnosed 
n=138 
 History of HIV care 
n=111 
 Current ART use 
n=96 
Characteristic PR (95% CI) APR* (95% CI)  PR (95% CI) APR* (95% CI)  PR (95% CI) APR* (95% CI) 
Age (years)         
     18-24 0.89 (0.40, 2.01) 0.74 (0.30, 1.84)  0.91 (0.78, 1.07) 0.99 (0.86, 1.14)  0.90 (0.67, 1.17) 0.98 (0.74, 1.31) 
     25-29 0.84 (0.35, 2.02) 0.81 (0.34, 1.91)  0.87 (0.72, 1.04) 0.89 (0.73, 1.08)  0.88 (0.67, 1.17) 0.93 (0.70, 1.23) 
     ≥30 1.00 1.00  1.00 1.00  1.00 1.00 
Duration of sex 
work (years) 
        
     <1.0  1.58 (0.60, 4.19) 1.81 (0.62, 5.33)  1.02 (0.83, 1.25) 1.02 (0.83, 1.12)  0.78 (0.49, 1.25) 0.81 (0.49, 1.33) 
     1.0-1.9  1.73 (0.78, 3.83) 2.04 (0.85, 4.94)  0.79 (0.58, 1.09) 0.84 (0.63, 1.12)  0.82 (0.56, 1.20) 0.91 (0.62, 1.33) 
     2.0-2.9  0.81 (0.25, 2.58) 0.91 (0.28, 2.88)  0.95 (0.76, 1.17) 0.93 (0.75, 1.15)  0.87 (0.62, 1.21) 0.87 (0.60, 1.24) 
     ≥3.0  1.00 1.00  1.00 1.00  1.00 1.00 
Number of 
clients per week 
        
     ≤19 0.64 (0.31, 1.33) 0.67 (0.33, 1.36)  1.13 (0.98, 1.31) 1.12 (0.96, 1.30)  1.11 (0.89, 1.39) 1.10 (0.88, 1.38) 
     ≥20 1.00 1.00  1.00 1.00  1.00 1.00 
Condom use**         
     Inconsistent 1.42 (0.70, 2.86) 1.65 (0.79, 3.47)  0.94 (0.77, 1.14) 0.90 (0.75, 1.01)  1.12 (0.88, 1.43) 1.08 (0.84, 1.38) 
     Consistent 1.00 1.00  1.00 1.00  1.00 1.00 
PR: Prevalence Ratio; APR: Adjusted Prevalence Ratio; CI: Confidence Interval 
*adjusted for all other variables in table 
†
Inconsistent includes FSW who responded “never”, “rarely”, “sometimes”, or “most times”; Consistent includes FSW who responded “always”. 
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CHAPTER V: SUBSTANCE USE AND AWARENESS OF HIV INFECTION 
AMONG HIV-INFECTED FEMALE SEX WORKERS IN LILONGWE, MALAWI  
Introduction 
Female sex workers (FSW) have been a key focus for HIV prevention efforts for over 
three decades; however, these women remain disproportionately at risk for acquiring 
HIV.[29-34]  The global burden of HIV among FSW is approximately 12%.[30]  The 
prevalence among FSW is even higher in sub-Saharan Africa, at approximately 37%.[14, 30, 
35]  In Malawi, the HIV prevalence among FSW is about 70%, the highest FSW prevalence 
globally.[30, 141]  To prevent ongoing transmission and successfully engage in HIV care and 
treatment, FSW must be aware of their HIV infection.   
Timely HIV testing and infection awareness is the pivotal first step for successful 
engagement in HIV care and treatment and subsequent improvements in health outcomes.  
Currently, the World Health Organization (WHO) currently recommends that HIV testing for 
high risk persons, such as FSW, should occur at least every 12 months.[142]  Yet, many 
FSW do not access HIV testing and counseling fearing a positive result.[41]  Among FSW 
who are aware of their HIV infection, many learn it as a result of testing during pregnancy.  
The most common reason for voluntary HIV testing is frequent illness or deterioration of 
health.[41]  The barriers to HIV testing for hard-to-reach FSW in sub-Saharan Africa must be 
delineated to improve uptake of HIV care and treatment and prevent ongoing transmission. 
Substance-using FSW in the region use alcohol most commonly.[4, 143, 144]  FSW 
often engage in alcohol use  to facilitate soliciting sex and cope with stressors associated with 
sex work.[3, 4]  In Malawi, nearly 45% of FSW report consuming four to five bottles of 
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alcoholic beverages per day, which puts these women at serious risk for alcohol 
dependency.[8, 41, 57]  Alcohol use negatively affects health care utilization and likely 
serves as a barrier to HIV infection awareness.[58, 145]  To date, the association between 
alcohol use and HIV testing, particularly among FSW in sub-Saharan Africa, has rarely been 
examined.[146]   
Marijuana is widely used in sub-Saharan Africa, including among FSW.[2, 143, 147, 
148]  FSW in South Africa are significantly more likely to use marijuana when compared to 
non-sex worker females, with two thirds reporting marijuana use.[3]  Estimates of marijuana 
use among FSW in Malawi are lacking, nonetheless, marijuana is widely available and 
inexpensive.[24, 25, 72]  Marijuana use impairs cognitive functions and judgment, which 
may in turn adversely affect HIV-related health seeking decision making and likely 
subsequent delay of HIV infection awareness. [69-71]  However, the relationship of 
marijuana use with HIV testing and infection awareness specifically among FSW is 
unknown.       
In this study, we examined associations between alcohol and/or marijuana use and 
lack of awareness of HIV infection among FSW in Lilongwe, Malawi.  We also describe 
history of HIV testing among HIV-infected FSW.   
Methods 
Study setting and participants 
 This study was conducted in Lilongwe, the central region of the Republic of Malawi.  
The study population included FSW, defined per the Family Planning Association of Malawi 
as someone “who had received money in exchange for sex either regularly or occasionally up 
to 12 months prior to the survey”, who were at least 18 years of age, and able to speak 
English or Chichewa, the predominant local language. 
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Study design 
 
 Our study was guided by self-regulation and coping theories that individuals engage 
in substance use to help cope with negative life events and dysregulate emotional states 
brought on by sex work, which in turn may influence HIV health seeking behaviors.[73-75]  
We designed and implemented this study through a collaboration among the University of 
North Carolina-Chapel Hill, UNC Project-Malawi, and Theatre for a Change (TfaC), a non-
governmental organization in Malawi with far-reaching relationships with local stakeholders 
including sex workers, chiefs, police, other NGOs, United Nations agencies, and government 
ministries.  We employed a cross-sectional design to systematically recruit FSW using 
venue-based sampling, a strategy with documented success in identifying hidden populations, 
such as FSW.[12, 95-98]  Using a mobile van, we recruited FSW using an outreach team 
comprised of a peer FSW, HIV testing counselors, interviewers, a study nurse, and male 
driver.  The list of venues was developed in collaboration with TfaC.  Prior to recruitment, 
stakeholder meetings with FSW community leaders known as “Queen Mothers” were held in 
conjunction with TfaC and the UNC Project-Malawi community advisory board to navigate 
the legal and social networks involved with sex work.  FSW were recruited for participation 
from July to September 2014 from 23 different venues, primarily bars and bottle shops, 
within Lilongwe. 
Data collection 
All consenting FSW received a behavioral survey.  With the behavioral survey, we 
obtained detailed information on self-reported alcohol and marijuana use and HIV testing 
history, as well as sociodemographic information, number of pregnancies, depression, and 
sex work factors (length of time in sex work, number of weekly clients, condom use, and 
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location of soliciting sex).  The survey was translated from English to Chichewa and back-
translated.  The survey was available in both languages to all participants.   
HIV serostatus was assessed for all participating FSW.  Per Malawian National HTC 
guidelines, FSW received serial HIV-antibody rapid tests, Determine HIV-1/2 and Uni-Gold 
rapid HIV-antibody.  Pre- and post-HIV test counseling, clinic referral, and risk reduction 
counseling were administered, and both male and female condoms were offered.   
Substance use assessments 
 
Alcohol use was assessed using the WHO’s Alcohol Use Disorders Identification 
Test (AUDIT).[110, 149, 150]  The AUDIT is an internationally-validated screening tool that 
measures alcohol use behaviors and alcohol use disorder symptoms.[111, 112]  The AUDIT 
comprises 10 questions related to specific domains, like hazardous drinking, harmful 
drinking, and alcohol dependence symptoms.  Hazardous alcohol use is an alcohol 
consumption pattern that increases the risk of harmful consequences of the person or others.  
Harmful alcohol use is an alcohol consumption pattern that leads to adverse physical and 
mental health outcomes.  Alcohol dependence is a condition in which a person experiences a 
strong desire to drink and difficulty controlling alcohol use.  Each of the 10 questions has a 
set of responses with a corresponding score of 0 to 4.  Scores from each question are added, 
resulting in one composite score ranging from 0 to 40, with higher scores correlated to 
having an alcohol use disorder.  FSW with an AUDIT score of 0 to 6 will be indicative of 
abstinence or non-hazardous drinking, 7 to 15 of  hazardous drinking, 16 to 19 of harmful 
drinking, and ≥20 of possible alcohol dependency.[110]   
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Marijuana use was measured in terms of reported lifetime marijuana use and number 
of days using marijuana within the past 30 days.  Current marijuana use was defined as at 
least one day of marijuana use within the prior 30 days.   
HIV infection awareness assessment 
 To measure HIV infection awareness, we asked FSW to report the results of their last 
HIV test.  FSW who were HIV-seropositive and self-reported themselves as HIV-negative 
from last HIV test, never receiving their results from an HIV test, or never previously tested 
for HIV were considered unware of HIV infection.  
Covariates 
We used directed acyclic graphs, based on the literature, to identify a minimally 
sufficient adjustment set of covariates to include in our analysis of the associations between 
alcohol and marijuana use, alone and together, with lack of HIV infection awareness.  
Covariates examined included s age (18-24, 25-29, ≥30 years), education (never attended 
school/only primary school, any secondary school/more school), marital status (never 
married, cohabitating/married, separated/divorced/widowed), housing (private house, bottle 
shop/bar, hotel/guesthouse), gravidity (no previous pregnancies, any previous pregnancies), 
financial dependents (no dependents, any dependents), probable depression measured by the 
Patient Health Questionnaire-9  (PHQ9 <10, PHQ9 ≥10),[113-115] and treatment for an STI 
in the prior 12 months (no, yes).  We also examined were years in sex work (<1, 1.0-1.9, 2.0-
2.9, ≥3.0 years), location for soliciting paying sexual partners (bar/bottle shop, other), weekly 
number of clients (<10, 10-19, 20-29, ≥30 clients), condom use during vaginal sex with 
clients in prior 7 days (consistent use, inconsistent use),  ever had a client that demanded not 
using a condom during vaginal sex (no, yes), alcohol use prior to last vaginal sex with client 
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(no, yes), and any marijuana use prior to last vaginal sex with client (no, yes).  Categorization 
of the covariates were based on interpretability and replicability.   
Statistical analysis 
 
Sociodemographic characteristics, sexual history, history of HIV testing, and 
substance use were summarized using frequencies and proportions for categorical variables 
and medians and interquartile ranges (IQR) for continuous variables.   
We conducted analyses for the associations of alcohol and marijuana use with the 
primary outcome of lack of HIV infection awareness.  We developed a product interaction 
term to assess the association between alcohol and marijuana use together and lack of HIV 
infection awareness.  We also explored the association between alcohol and marijuana use 
and time since most recent HIV testing (≤12 months vs. ≥12 months) among FSW unaware 
of their HIV infection.  We used Poisson regression with robust variance estimates to 
estimate bivariable and, when sample size permitted, multivariable prevalence ratios (PR) 
with 95% confidence intervals (CI), due to problems with consistent convergence of log-
binomial regression models.[118, 119]   
Potential confounders were assessed one-by-one, and retained in final adjusted 
multivariable models if removal resulted in a >10% change in the prevalence ratio estimate.  
Interactions were only considered for variables of interest that met positivity assumptions and 
were retained in the final adjusted multivariable models if they had public health relevance 
and reached statistical significance at alpha=0.10.  Collinearity was evaluated in the model 
using Pearson’s correlation coefficient; none of the covariates showed significant correlation 
(p-value ≥0.5).  
All analyses were conducted using SAS 9.3 (SAS Institute, Cary, NC, USA).   
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Ethics 
 The research protocol, survey, and consent forms were reviewed and approved by the 
Institutional Review Board at the University of North Carolina and the Malawi Ministry of 
Health and Population National Health Sciences Research Committee (HSRC).  All 
participants provided written informed consent prior to completing study activities.  All study 
related activities were conducted in a safe and private location.    
Results  
Of the total study population of 200 FSW, 138 (69%) had confirmed HIV infection 
(Table 1).  About half (41%) of those HIV-infected were between the ages of 18 and 24 years 
and most (66%) never attended school or received only primary school.  Most (85%) were 
separated, divorced, or widowed, and approximately 60% lived in a bar or bottle shop.  
Nearly all (92%) HIV-infected FSW had at least one previous pregnancy.  A quarter (24%) 
of HIV-infected FSW had received treatment for an STI in the prior 12 months per self-
report.  The median time exchanging sex for money was 3 years (interquartile range: 1-6) and 
the median number of clients per week was 21 (IQR: 10-35).  About two-thirds (64%) 
reported ever having a client who demanded not using a condom during vaginal sex.  Nearly 
a third (30%) reported alcohol use prior to last vaginal sex act with a client, with less than 
10% reporting any marijuana use prior to last vaginal sex act with a client. 
HIV testing and infection awareness 
Of those HIV-infected, 111 (80%, 95% CI: 73, 87%) were aware of their HIV 
infection (Table 2).  Among the 20% who were unaware of being HIV-infected, 20 (74%) 
had tested negative previously, 5 (19%) had never been tested, and 2 (7%) had been tested 
but had never received results.[141]  The majority of unaware HIV-infected FSW had tested 
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most recently more than 12 months prior (41%), followed by 32% testing within 6 months 
prior.  About three-fourths (77%) received the last HIV test at a governmental health center.     
Substance use 
Using the AUDIT scale, less than half (45%) of all HIV-infected FSW were non-
hazardous drinkers, while 28% were hazardous drinkers, 12% were harmful drinkers, and 
15% were alcohol dependent (Table 3).  FSW who were unaware of their HIV infection were 
more likely to be harmful drinkers (19%) or dependent drinkers (26%) when compared to 
FSW who were aware of their HIV infection.  The proportion of FSW reporting current 
marijuana use was similar among FSW unaware (23%) and aware of their HIV infection 
(26%).  The proportion of both harmful and dependent alcohol drinking and current 
marijuana use was also comparable among FSW who were unaware (11%) and aware (8%) 
of their HIV infection.  
Substance use and HIV infection awareness 
 Among HIV-infected FSW, dose-response relationship was observed for alcohol use 
and lack of HIV infection awareness (Table 4).  When compared to non-hazardous drinkers, 
FSW who were hazardous drinkers (adjusted PR: 1.24, 95% CI: 0.46, 3.37) or harmful 
drinkers (adjusted PR: 2.72, 95% CI: 0.97, 7.60) were more likely to be unaware of their HIV 
infection, in multivariable analysis including adjusting for duration in sex work, alcohol use 
prior to last vaginal sex with a client, and number of clients per week.  FSW who were likely 
dependent drinkers were 2.99 (95% CI: 1.31, 6.81) times as likely to be unaware of their HIV 
infection compared to FSW with non-hazardous drinkers, after adjusting for duration in sex 
work, alcohol use prior to last vaginal sex with a client, and number of clients per week.  
Specifically among FSW who were unaware of their HIV infection and previously tested, 
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FSW who were harmful drinkers or alcohol dependent were 0.91 (95% CI: 0.45, 1.85) times 
as likely to most recently receive an HIV test in the prior 12 months than FSW who were 
nonhazardous or hazardous drinkers in bivariable analysis. 
Comparing current to non-current marijuana use, the prevalence ratio of lack of HIV 
infection in multivariable analysis was 1.14 (95% CI: 0.53, 2.45), adjusting for marital status 
and number of clients per week.  In bivariable analysis comparing harmful/alcohol 
dependence and current marijuana use to non-hazardous/hazardous drinking and no current 
marijuana use, the prevalence ratio was 1.82 (95% CI: 0.59, 5.59).   
Discussion 
In this population of HIV-infected FSW in Lilongwe, surprisingly a majority of HIV-
infected FSW were aware of their HIV infection.  However, among those that were unaware 
of their HIV infection, a considerable proportion had previously tested more than 12 months 
prior to our study.  Nearly half of HIV-infected FSW reported at least hazardous and harmful 
alcohol consumption, with many dependent drinkers.  We observed a dose-response 
relationship between increased levels of alcohol use and lack of HIV infection awareness.  
FSW who were dependent drinkers were significantly more likely to be unaware of their HIV 
infection compared to FSW with non-hazardous alcohol consumption patterns. Marijuana 
use, alone and together with alcohol use, was uncommon and weakly associated with lack of 
HIV infection awareness. 
The proportion of HIV-infected FSW in our Lilongwe sample who were unaware of 
their HIV infection was unexpectedly lower when compared to previous estimates among 
FSW in sub-Saharan Africa.  Up to 60% of HIV-infected FSW in sub-Saharan Africa are 
unaware of their HIV infection, with most FSW only learning of their infection at antenatal 
care clinics during pregnancy.[22, 151]  In Malawi, a 2011 national-level size estimation, 
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enumerating the number of active FSW, reported that nearly three-quarters of all FSW were 
unaware of their HIV status.[41]  Unfortunately, HIV testing to determine current HIV 
infection was not conducted, therefore the proportion of unaware HIV-infected FSW could 
not be estimated, limiting the ability to explore the potential impact of not knowing one’s 
infection on care and forward transmission.  Our sample of FSW in Lilongwe was recruited 
from venues identified by our implementing partner, TfaC.  It is likely that FSW within our 
sample may have previously participated in TfaC sexual and reproductive health promotion 
programs, therefore, may be more likely to be aware of their HIV infection.  Furthermore, the 
large majority of our FSW reported previous pregnancies and may have undergone 
compulsory HIV testing as part of antenatal care.   
FSW unaware of their HIV infection were testing infrequently, as the majority had 
previously tested more than 12 months prior to our study.  The WHO recommends high-risk 
persons should receive HIV testing at least every 12 months.[142]  Most of the FSW in our 
study that were unaware of their HIV infection had a previous HIV test outside of the WHO 
recommended HIV testing period.  Strategies that increase the frequency of testing, such as 
venue-based HIV testing, must be implemented to reach FSW and improve HIV infection 
awareness. 
Notably, a sizeable proportion of those HIV-infected and unaware of their HIV 
infection had previously tested negative six months prior to our study.  It is possible that this 
proportion of FSW had recently acquired HIV and therefore less opportunity for becoming 
aware of their HIV infection.  Given these likely recent HIV infections, FSW in Malawi 
should be encouraged to receive HIV testing and counseling more frequently than every 12 
months to prevent ongoing transmission and access timely HIV care and treatment.  HIV-
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infected FSW who delay HIV testing may not adequately engage in HIV care and treatment 
and continue to unknowingly transmit HIV through high-risk sexual behaviors.  However, 
previously in our study, we found little difference in sexual risk behaviors between HIV-
uninfected and infected FSW.[141]  Given the continued engagement in sexual risk 
behaviors, it will be imperative for FSW to receive a timely HIV diagnosis and infection 
awareness to then engage in proper HIV care and treatment. 
Alcohol use among HIV-infected FSW in Lilongwe was prevalent. The high 
prevalence of alcohol use among HIV-infected FSW may be due to living and working in an 
environment where alcohol is readily available.  The majority of HIV-infected FSW in our 
sample reported currently living and soliciting sex at a bar or bottle shop  FSW in similar 
settings who worked at bars or other alcohol venues were more likely to consume alcohol or 
binge drink when compared to FSW not working in alcohol serving venues.[4, 8, 11]  The 
prevalence of alcohol use may have been lower if more non-venue-based FSW had been 
included in our sample; regardless, our prevalence is consistent with previous high 
prevalence estimates of alcohol use among FSW recruited within the larger community and 
clinic settings in sub-Saharan Africa.[4, 143, 152, 153]   To reduce the prevalence of alcohol 
use, FSW in Lilongwe should be reached using a venue-based approach for alcohol risk 
reduction efforts. 
We found in this population that increased alcohol consumption was associated with 
lack of HIV infection awareness.  Although scarcely examined, one study in Kenya among 
FSW found that harmful alcohol drinkers (AUDIT score 7-15) were more likely to self-report 
never having been tested HIV, compared to hazardous alcohol drinkers (AUDIT score 16-
19).[146]  However, this study was restricted to FSW who drank regularly with hazardous or 
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harmful drinking (AUDIT scores ranging from 7 to 19).  Our results not only suggest a 
relationship between alcohol dependence and lack of HIV infection awareness among HIV-
infected FSW in Lilongwe, but a dose-response relationship between increased alcohol use 
and lack of HIV infection awareness.   
Our association between alcohol use and lack of HIV infection awareness may be due 
to alcohol use influencing sexual risk behaviors leading to increased recent HIV infections 
and less time to obtain HIV testing.[4, 8, 34, 152, 154]  However, among those that were 
unaware of their HIV infection and previously tested, we found little to no association 
between alcohol use and receiving an HIV test in the prior 12 months.  Therefore it is likely 
more plausible that alcohol use adversely influences health seeking behaviors and therefore 
inhibits HIV testing and HIV infection awareness.[58, 145]  Alcohol use likely predates lack 
of awareness of HIV infection for FSW within our sample of unaware HIV-infected FSW, 
regardless of the cross-sectional nature of our study, as alcohol use was ascertained prior to 
determination of HIV among those reporting previously never testing or HIV-negative.  
Targeted alcohol reduction interventions must be explored as a means to expand HIV 
infection awareness for FSW.        
Among HIV-infected FSW in Lilongwe, current marijuana was uncommon.  Our 
results add to the limited knowledge base documenting marijuana use among FSW sub-
Saharan Africa.  Research on marijuana use among FSW has predominantly occurred in 
urban areas of South Africa.[143, 155]  FSW in South Africa report marijuana as the most 
commonly used substance behind alcohol, with approximately 70% reporting marijuana 
use.[143, 155]  It is possible that FSW in our sample were more likely to use alcohol than 
marijuana since alcohol may be more readily available given our sample of FSW recruited 
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from mainly alcohol-serving venues.  Our estimate of current marijuana use may be an 
underestimate of marijuana use among FSW in Malawi not living or working in alcohol-
serving venues.       
Marijuana use, alone or together with alcohol use, was weakly associated with HIV 
infection awareness.  A qualitative study among street-based FSW using marijuana found 
that most FSW reported receiving an HIV test at some point but some reported never testing 
for HIV.[155]  The most commonly mentioned barriers to HIV testing for FSW were 
negative treatment by t by health care professionals and limited HIV testing locations.[155]  
These non-substance-use-related barriers highlight the multilevel nature of barriers to HIV 
testing among FSW and may account for our lack of association between marijuana use and 
HIV infection awareness among HIV-infected FSW in Lilongwe.  It is also possible that 
severe marijuana use, which was not examined within our study, may more directly affect 
HIV infection awareness.  Future research with improved marijuana use assessments are 
needed to examine the frequency, duration, and severity of marijuana use.  
These findings emphasize the importance of improving HIV testing uptake to 
increase infection awareness as a first step to engaging in HIV care and treatment and 
improving health outcomes for HIV-infected substance-using FSW in Malawi.  Targeted 
strategies including venue-based HIV testing and counseling, are necessary to better reach 
alcohol-using FSW for frequent and consistent HIV testing to deliver a timely HIV diagnosis 
and infection awareness.  Venue-based alcohol reduction strategies must be explored to 
mitigate alcohol use and to expand HIV infection awareness among highly active FSW in 
Malawi.          
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Table 6. Characteristics of HIV-infected female sex workers in Lilongwe, Malawi, July-
September 2014, n=138 
  n (%) 
Age (years)    
     18-24  57 (41) 
     25-29  44 (32) 
     ≥30  37 (27) 
Education    
     Never attend or only primary school  91 (66) 
     Any secondary or more school  47 (34) 
Marital status    
Never married  15 (11) 
Married (legal or traditional) or co-habitating  6 (4) 
Separated, divorced, or widowed  117 (85) 
Housing    
Private house  17 (12) 
Bar or bottle shop  80 (58) 
Guesthouse or hotel  41 (30) 
Number of pregnancies    
     0  11 (8) 
     ≥1  127 (92) 
Number of financial dependents         
0  6 (4) 
≥1  132 (96) 
Depression    
     No probable depression  125 (91) 
     Probable depression  13 (9) 
Treated for an STI in prior 12 months    
     No  105 (76) 
     Yes  33 (24) 
Duration of sex work (years)    
     <1.0  15 (11) 
     1.0-1.9  24 (17) 
     2.0-2.9  22 (16) 
     ≥3.0  77 (56) 
Location for soliciting clients    
     Bar or bottle shop  124 (90) 
     Other  14 (10) 
Number of clients per weeka    
     <10  27 (20) 
     10-19  33 (24) 
     20-29  33 (24) 
     ≥30  44 (32) 
Condom use with client in past 7 days    
Inconsistent  36 (26) 
Consistent  102 (74) 
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Ever had a client demand not using a condom during 
vaginal sex 
   
     No  50 (36) 
     Yes  88 (64) 
Alcohol use prior to last vaginal sex with client    
     No  97 (70) 
     Yes  41 (30) 
Drug use prior to last vaginal sex with client    
No  129 (93) 
Yes   9 (7) 
a Missing data due to not knowing or refused to answer: number of clients in past 7 days: n=1  
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Table 7. Frequency and history of HIV testing by HIV infection awareness among previously tested HIV-infected female sex 
workers in Lilongwe, Malawi, July-September 2014 
 All  
(n=133) 
 Unaware of HIV 
infection 
(n=22) 
 Aware of HIV 
infection 
(n=111) 
 median (IQR)  median (IQR)  median (IQR) 
Number of lifetime HIV tests 2 (2-4)  3 (2-4)  2 (2-4) 
         
 n (%)  n (%)  n (%) 
Time since last HIV test (months)         
     ≤ 6 42 (32)  7 (32)  35 (32) 
     6.1-11.9 26 (27)  6 (27)  20 (18) 
     ≥ 12.0 65 (49)  9 (41)  56 (50) 
Location of most recent HIV testa         
     Health center, governmental 95 (71)  17 (77)  78 (70) 
     Private clinic 13 (10)  1 (5)  12 (11) 
     HIV/AIDS comprehensive care and treatment clinic 7 (5)  0 (0)  7 (6) 
     Other 16 (12)  4 (18)  12 (11) 
IQR: interquartile range 
a Missing due to not knowing most recent HIV test location, n=2 
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Table 8. Patterns of alcohol and marijuana use by HIV infection awareness among previously tested HIV-infected female sex 
workers in Lilongwe, Malawi, July-September 2014 
Substance use 
All 
(n=138) 
 Unaware of 
HIV 
infection 
(n=27) 
 Aware of 
HIV 
infection 
(n=111) 
 n (%)  n (%)  n (%) 
Alcohol use (AUDIT)         
Non-hazardous drinking (score 0-6) 62 (45)  9 (33)  53 (47) 
Hazardous drinking (score 7-15) 39 (28)  6 (22)  33 (30) 
Harmful drinking (score 16-19) 17 (12)  5 (19)  12 (11) 
Alcohol dependence (score ≥20) 20 (15)  7 (26)  13 (12) 
         
Marijuana use         
No current marijuana use 105 (76)  20 (74)  85 (77) 
Current marijuana usea 33 (24)  7 (26)  26 (23) 
         
Alcohol and marijuana use         
Non-hazardous/hazardous drinking and no current marijuana use 80 (58)  11 (41)  69 (63) 
Harmful/alcohol dependent and no current marijuana use 25 (18)  9 (33)  16 (14) 
Non-hazardous/hazardous drinking and current marijuana use 21 (15)  4 (15)  17 (15) 
Harmful/alcohol dependent and current marijuana use 12 (9)  3 (11)  9 (8) 
AUDIT= Alcohol Use Disorder Identification Test 
a Current use defined as reported use in past 30 days 
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Table 9. Associations of alcohol and marijuana use, alone and together, with lack of HIV infection awareness (n=138) 
 Unaware of HIV infection 
 Unadjusted 
PR (95% CI) 
Adjusted 
PR (95% CI) 
Alcohol use (AUDIT) 
Non-hazardous drinking (score 0-6) 1.00 1.00 
Hazardous drinking (score 7-15) 1.06 (0.341, 2.75) 1.24 (0.46, 3.37)a 
Harmful drinking (score 16-19) 2.03 (0.78, 5.25) 2.72 (0.97, 7.60)a 
Alcohol dependence (score ≥20) 2.41 (1.03, 5.64) 2.99 (1.31, 6.81)a 
   
Marijuana use   
No current marijuana use 1.00 1.00 
Current marijuana use 1.11 (0.52, 2.40) 1.14 (0.53, 2.45)b 
   
Alcohol and marijuana use 
Non-hazardous/hazardous drinking and no current marijuana use 1.00  
Harmful/alcohol dependent and no current marijuana use 2.62 (1.23, 5.59) - 
Non-hazardous/hazardous drinking and current marijuana use 1.39 (0.49, 3.91) - 
Harmful/alcohol dependent and current marijuana use 1.82 (0.59, 5.59) - 
PR=prevalence ratio; CI=confidence interval; AUDIT= Alcohol Use Disorder Identification Test 
a Adjusted for duration in sex work (years), alcohol use prior to last vaginal sex with client, and number of clients per week 
b Adjusted for marital status and number of clients per week 
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CHAPTER VI: THE ASSOCATION BETWEEN SUBSTANCE USE AND SUB-
OPTIMAL HIV TREATMENT OUTCOMES AMONG HIV-INFECTED FEMALE 
SEX WORKERS IN LILONGWE, MALAWI   
Introduction 
Substance use is highly prevalent among female sex workers (FSW) globally.[1-7]  
FSW often engage in substance use to facilitate soliciting clients and to cope with stigma and 
stress related to sex work.[1, 4, 8-10]  Substance-using FSW have particularly low condom 
usage and high rates of sexual abuse and sexually transmitted infections (STI), which 
disproportionately place substance-using FSW at high risk for HIV infection.[2, 11-13] 
FSW are a key population affected by HIV.  The global HIV prevalence among FSW 
is 12%, with a prevalence of 37% among FSW in sub-Saharan Africa.[30]  The HIV 
prevalence is highest among FSW in Malawi, with approximately 70% of FSW living with 
HIV.[141]  To improve health outcomes and ongoing transmission, HIV-infected FSW must 
use antiretroviral therapy (ART) and become virally suppressed.  Engagement in HIV 
treatment may be a particular challenge among FSW in sub-Saharan Africa.[14, 21, 22]   
For FSW, one potential barrier to engagement in HIV treatment is substance use.  The 
heavy use of alcohol and/or marijuana, the most commonly used substances in Malawi, 
severely affects cognitive functions, such as decision-making and memory.[59, 61, 67, 68] 
Lack of these cognitive skills may make it increasingly difficult for substance users to 
manage their HIV treatment.[59, 61, 69-71]  Substance-using FSW who are not successfully 
engaged in HIV treatment will not benefit immunologically or clinically and may continue to 
transmit HIV to their sexual partners.  To improve health outcomes and reduce ongoing 
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transmission, the impact of substance use on engagement in HIV treatment among FSW must 
be understood. 
  For this study, we examined the association between alcohol and marijuana use and 
sub-optimal HIV treatment outcomes: lack of ART use among ART-eligible and viral 
nonsuppression, among HIV-infected FSW in Lilongwe, Malawi.                  
Methods 
Study setting and participants 
This study was conducted in Lilongwe, Malawi, where a 2011 situation analysis 
estimated 3,500 FSW working.  Our study population included women who were at least 18 
years of age, were either aware or unaware of their HIV status, able to speak English or 
Chichewa, the predominant local language, and self-identified as a FSW using the 2011 
situation analysis definition (“received money in exchange for sex either regularly or 
occasionally up to 12 months prior to the survey”). 
Study design 
 Our study was designed and implemented through a collaboration between University 
of North Carolina-Chapel Hill, UNC Project-Malawi, and Theatre for a Change, a non-
governmental organization in Malawi.  We used a cross-sectional design systematically 
recruiting FSW using venue-based sampling, a well-documented successful strategy for 
identifying hidden population, such as FSW.[12, 95-98]  We identified FSW using an 
outreach team made up of HIV testing counselors, interviewers, a study nurse, a male driver, 
and a peer FSW, to assist with approaching women at the venues.  Through July and 
September 2014, we recruited FSW for participation from 23 different venues within 
Lilongwe that were primarily bars and bottle shops. 
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Data collection 
All consenting FSW completed a behavioral survey seeking detailed information on 
alcohol and marijuana use and HIV treatment engagement.  We also obtained 
sociodemographics factors, number of pregnancies, number of financial dependents, 
depression, previous STI treatment and sexual history.  The survey was translated and back 
translated from English to Chichewa.  The survey in both languages was available to all 
FSW. 
We used the Malawian National HIV Testing and Counseling guidelines to assess and 
confirm serostatus for all participating FSW.  FSW received serial HIV-antibody rapid tests, 
Determine HIV-1/2 and Uni-Gold rapid HIV-antibody.  Based on the national guidelines, 
persons with serodiscordant test results underwent tiebreaker tests using Determine and Uni-
Gold parallel testing.  We administered pre- and post-testing counseling, clinic referral, and 
risk reduction counseling.  We also offered male and female condoms to all FSW 
participants. 
For all confirmed HIV-seropositive FSW, we obtained CD4 measurements and 
plasma HIV-RNA levels.  CD4 measurement was obtained using a fingerstick blood sample 
and the Pima CD4TM  analyzer, a self-contained, cartridge-based test platform with results 
available in approximately 20 minutes.[84, 99]  We provided CD4 results using a trained 
study nurse to assist with interpretation of these results. 
Dried blood spots (DBS) were collected using fingerstick to determine HIV-1 RNA 
concentrations.[100-102]  DBS samples were stored in drying boxing with a humidity 
indicator card to monitor moisture levels, until they were brought to the UNC Project 
 77 
 
laboratory.  We obtained HIV-1 RNA levels within 4 weeks of DBS collection and a trained 
study nurse provided and explained results to FSW.   
Substance use assessment 
 We measured alcohol use using the World Health Organization’s (WHO) Alcohol 
Use Identification Test (AUDIT).[110, 149, 150]  The AUDIT is an internationally-validated 
screening tool that measures alcohol use behaviors and alcohol use disorder symptoms.[111, 
112]  The AUDIT comprises 10 questions related to specific domains, such as hazardous 
drinking, harmful drinking, and alcohol dependence symptoms.  Hazardous alcohol use is an 
alcohol consumption pattern that increases the risk of harmful consequences of the person or 
others.  Harmful alcohol use is an alcohol consumption pattern that leads to adverse physical 
and mental health outcomes.  Alcohol dependence is a condition in which a person 
experiences a strong desire to drink and difficulty controlling alcohol use.  Each of the 10 
questions has a set of responses with a corresponding score of 0 to 4 that sums to a single 
composite score ranging from 0 to 40, with higher scores correlated to having an alcohol use 
disorder.  For this analysis, FSW with an AUDIT score of 0 to 6 was considered indicative of 
abstinence or non-hazardous drinking, 7 to 15 of hazardous drinking, 16 to 19 of harmful 
drinking, and ≥20 of alcohol dependency.[110]   
 Marijuana use was assessed by reports of lifetime marijuana and number of days 
using marijuana within the past 30 days.  We defined current marijuana use as FSW who 
reported using marijuana at least one day within the prior 30 days.   
   HIV treatment assessments 
 We asked FSW to report the date and results of their most recent HIV test to 
determine new vs. previous diagnosis.  We defined a new HIV diagnosis as FSW who were 
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seropositive, based HIV rapid testing, and self-reported being HIV negative at their most 
recent HIV test (or never testing previously).  We defined a previous diagnosis as those 
reporting being HIV-positive at their most recent test.   
We assessed reported current ART use among all ART eligible FSW.  ART eligibility 
was defined as those reporting current ART use, a CD4 ≤500 cells/mm3 following the 
Malawi national guidelines, currently pregnant or breastfeeding, or any pregnancy after July 
2011 following Option B+ policy.[116]  Option B+ provides confirmed HIV-infected 
pregnant and breastfeeding women lifelong ART regardless of CD4 count or clinical stage.  
FSW who answered no to the question “Are you currently on ART?” were classified as not 
using ART. 
 We measured HIV-1 RNA concentration for viral suppression.  FSW were classified 
as nonsuppressed with an HIV-1 RNA >5000 copies/mL which is the recommended 
threshold when using fingerstick DBS.[47, 103]   
Covariates 
We used directed acyclic graphs, based on the literature, to identify minimally 
sufficient adjustment sets of covariates to include in our models examining the associations 
between alcohol and marijuana use with sub-optimal HIV treatment outcomes.  The 
covariates we examined included age (18-24, 25-29, ≥30 years), education (never attended 
school/any primary school, any secondary school/more school), marital status (never 
married, cohabitating/married, separated/divorced/widowed), housing (private house, bottle 
shop/bar, hotel/guesthouse), gravidity (no previous pregnancies, any previous pregnancies), 
financial dependents (no dependents, any dependents), probable depression measured by the 
Patient Health Questionnaire-9  (PHQ9 <10, PHQ9 ≥10),[113-115] and treated for an STI in 
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the prior 12 months (no, yes).  We also examined were years in sex work (<1, 1.0-1.9, 2.0-
2.9, ≥3.0 years), location for soliciting paying sexual partners (bar/bottle shop, other), weekly 
number clients (<10, 10-19, 20-29, ≥30 clients), condom use during vaginal sex with clients 
in prior 7 days (consistent use, inconsistent use),  paying sexual partner demanded not using 
a condom for vaginal sex (no, yes), and alcohol use prior to last vaginal sex with client (no, 
yes).  Categorization of the covariates was based on interpretability and replicability.   
Statistical analysis 
 We summarized the characteristics, substance use, and engagement in HIV treatment 
using frequencies and proportions for categorical variables and medians and interquartile 
ranges (IQR) for continuous variables. 
We conducted separate analyses for the associations of alcohol and marijuana use 
with the primary outcomes of lack of ART use and nonsuppression.  Poisson regression with 
robust variance estimates was used to estimate bivariable and, when sample size permitted, 
multivariable prevalence ratios (PR) with 95% confidence intervals (CI).[118, 119]   
We assessed potential confounders one-by-one, and retained them in the final 
adjusted multivariable models if removal resulted in a >10% change in estimate.  Interactions 
were only considered for variables of interest that met positivity assumptions and were 
considered to have public health relevance; they were retained in final adjusted multivariable 
models if they reached statistical significance at alpha=0.10.  Collinearity was evaluated in 
the model using Pearson’s correlation coefficient; none of the covariates showed significant 
correlation (p value ≥0.5).  
All analyses were conducted using SAS 9.3 (SAS Institute, Cary, NC, USA).   
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Ethics statement 
Ethics approval was obtained for all study-related procedures and materials from the 
Malawi Ministry of Health and Population National Health Sciences Research Committee 
(HSRC) and the University of North Carolina-Chapel Hill Institutional Review Board.  All 
participants provided written informed consent prior to completing study activities.  All 
study-related activities were conducted in a safe and private location.    
Results 
Among the 200 enrolled FSW, 111 (56%) were previously diagnosed and confirmed 
HIV-infected.  Of those previously diagnosed, 96 (86%) were considered eligible for ART.  
Among those ART-eligible, the median age was 26 (IQR: 23-30).  Approximately 70% never 
attended school or received only primary schooling and 87% were separated, divorced, or 
widowed (Table 1).  Over half (58%) were living at a bar or bottle shop.  Almost all had a 
previous pregnancy (92%) and at least one financial dependent (96%).  About 10% were 
considered depressed based on the PHQ-9 criteria.  Three fourths self-reported receiving 
treatment for an STI in the prior 12 months.  The median time exchanging sex for money was 
3 years (interquartile range: 1-6) and number of clients per week was 20 clients (IQR: 10-35).  
Nearly one quarter (23%) reported inconsistent condom use with clients in the prior 7 days 
and 58% reported ever having a client demand not using a condom during vaginal sex.   
Among those eligible for ART, 29% (n=28) reported using alcohol prior to their last 
vaginal sex act with a client (Table 1).  Overall among ART-eligible FSW, over half (52%) 
had AUDIT scores ≥ 7.  One-third (30%) had patterns of hazardous drinking.  Over 20% 
were heavily consuming alcohol, 10% were harmful drinkers and 12% were alcohol 
dependent.  Twenty one percent of all ART-eligible FSW reported current marijuana use.       
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Of those eligible for ART (n=96), 25% (n=24) were not using ART and 75% (n=72) 
reported using ART.  FSW not using ART had a lower median CD4 count (391, IQR: 261-
474) and higher median viral load (86,345, IQR: 26,319-337,689) when compared to FSW 
who were using ART (Figure 1).    
The prevalence of ART non-use was 38% (n=8) among those who were harmful 
drinkers or alcohol dependent and 21% (n=16) among those who were non-hazardous or 
hazardous drinkers (Table 2).  In bivariable analysis, the prevalence ratio for no ART use 
among ART-eligible was 1.8 (95% CI: 0.9, 3.6) for harmful drinkers or alcohol dependent 
FSW compared to non-hazardous or hazardous drinkers.  In multivariable analyses, FSW 
who were harmful drinkers or alcohol dependent were 1.9 (95% CI: 1.0, 3.8) times as likely 
to not use ART compared to FSW who were not hazardous or hazardous drinkers, adjusting 
for number of clients per week, housing, and duration in sex work.    
Among the 72 FSW using ART, 14% (n=10) were nonsuppressed and 86% (n=62) 
were virally suppressed at the time of this study.  Of those using ART, the prevalence of 
nonsuppressed FSW was 23% (n=3) among those who were harmful drinkers or alcohol 
dependent and 12% (n=7) among those who were non-hazardous or hazardous drinkers.  The 
prevalence ratio for FSW nonsuppressed was 2.0 (95% CI: 0.6, 6.5) among harmful drinkers 
and alcohol dependent FSW compared to non-hazardous or hazardous drinkers in bivariable 
analysis.   
Of those ART-eligible, the prevalence of FSW not using ART was 35% (n=7) among 
current marijuana users.  The prevalence ratio of not using ART among ART-eligible FSW 
was 1.5 (95% CI: 0.8, 3.2) among current marijuana users compared to non-hazardous or 
hazardous drinkers, in bivariable analysis.  Upon adjusting for treatment for an STI in prior 
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12 months, FSW who were currently using marijuana were 1.9 (95% CI: 0.8, 4.6) times as 
likely to not use ART compared to FSW who were not currently using marijuana.   
In bivariable analysis, FSW who were currently using marijuana were 0.5 (95% CI: 
0.1, 3.6) times as likely to be virally nonsuppressed compared to FSW who were not 
currently using marijuana. 
Discussion 
 In our study, we identified a modest proportion of ART-eligible FSW who did not 
report ART use.  We found that heavy levels of alcohol use, such as harmful drinking or 
alcohol dependence, and marijuana use are associated with sub-optimal engagement in HIV 
treatment among HIV-infected FSW.  Specifically, FSW who were harmful drinkers or 
alcohol dependent were significantly more likely to not use ART.  Among FSW in our study, 
current marijuana use was uncommon but was associated with not using ART. 
 About three-quarters of ART-eligible FSW were using ART. This high level of ART 
use is likely a result of scaled-up ART coverage in Malawi.  ART coverage has expanded in 
Malawi through the provision of ART to all pregnant or breastfeeding HIV-infected women 
(Option B+) beginning in July 2011 and earlier initiation of ART (CD4 count ≤500 
cells/mm3) in April 2014.[131]  Given this recent expansion of ART in Malawi, we expected 
most ART-eligible FSW in our sample to report ART use.   
For the remaining ART-eligible FSW that were not using ART, we were unable to 
determine the timing for ART-eligibility.  Our study began shortly after the expanded ART 
guidelines were implemented in Malawi.  The FSW we identified as ART-eligible through 
our study may have previously been ineligible to initiate ART due to a high CD4 count.  
Among FSW that were aware of their HIV status and identified through our study as ART-
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eligible, the most commonly reported reason for not being on ART was a prior high CD4 
count.[156]      
 Within our study, heavy alcohol use was associated with lack of ART use among 
ART-eligible FSW.  The adverse influence of alcohol use on ART use has been well-
documented globally.[60, 157, 158]  Alcohol use may impede ART use through several 
plausible pathways.  First, alcohol intoxication impairs memory, organizational skills, 
judgement and other cognitive abilities likely resulting in lack of ART initiation or treatment 
interruptions.[59, 61, 67, 68, 157]  Lacking cognitive skills from heavy alcohol use may not 
only impede a person’s health-care seeking behavior but may also influence health-care 
providers’ decision for providing ART.  Health-care providers may withhold providing ART 
to heavy alcohol users, despite eligibility, because heavy alcohol users are viewed as 
incapable to competently use ART.[159]  Further influencing treatment among alcohol users 
are the beliefs that ART medications should not be mixed with alcohol and therefore ART 
should be not be used when consuming alcohol.[160, 161]  In the context of our study, the 
mechanisms that most influence the relationship between alcohol use and lack of ART are 
unknown, and future work is needed to improve ART uptake among ART-eligible FSW in 
Malawi. 
 To our knowledge, this study is one of the first to examine alcohol use and viral 
suppression among FSW in sub-Saharan Africa.  Alcohol use among HIV-infected persons in 
sub-Saharan Africa has been identified as an important predictor of viral nonsuppression.[60, 
159]  Viral nonsuppression is generally a result of poor ART adherence among persons on 
ART.  However, alcohol may have a direct effect on viral nonsuppression by increasing HIV 
viral replication.[162-164]    Regardless of the mechanism, targeted interventions for HIV-
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infected FSW should focus on alcohol reduction and ART adherence to improve viral 
suppression and health outcomes, and to prevent ongoing transmission. 
FSW often use alcohol to facilitate sex work and to cope with their work and high-
risk environments.[1, 4, 8-10]  The observed prevalence of heavy alcohol use may be driven 
by FSW living at alcohol-serving venues.  Given the strategy used for recruitment, nearly all 
of the FSW in our sample reported living and soliciting sex in a bar or bottle shop.  In similar 
studies, FSW who worked at bars or other alcohol venues were more likely to consume 
alcohol or binge drink when compared to FSW not working in alcohol-serving venues.[4, 8, 
11] 
 Marijuana use was not as common as alcohol use among FSW in Lilongwe.  Our 
results contribute to the limited knowledge of marijuana use among FSW in sub-Saharan 
Africa, which has primarily come from urban areas of South Africa.[3, 155]  Approximately 
70% of FSW in South Africa report using marijuana.[3]  Marijuana use was noticeably 
higher among FSW in South Africa than our sample of FSW in Malawi.  The lower 
prevalence of marijuana use observed in our study may be due to our sample of FSW, who 
were predominantly living at alcohol-serving venues.  Marijuana use may be more common 
among FSW who are not living in environments where alcohol is readily available.     
 Within our sample of FSW, marijuana use influences ART use however, the 
prevalence of virally non-suppressed FSW that reported current marijuana use was too low to 
draw meaningful conclusions of this relationship.  The pathways of both alcohol and 
marijuana use affecting HIV treatment are analogous.  Similar to alcohol, marijuana use 
affects cognitive functions that are necessary for decision-making and judgement.[59, 61, 67, 
68, 158]  In addition to impairments of cognitive skills, heavy marijuana use does negatively 
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affect ART adherence.[71, 165]   Although not presented as part of this analysis, the majority 
of marijuana users were less likely to be heavy drinkers, perhaps suggesting that heavy 
alcohol use may play a more important role on viral nonsuppression than current marijuana 
use.  For our present study, we only examined current marijuana use, so it is possible that 
severe marijuana use could negatively influence HIV treatment, specifically viral 
nonsuppression, for FSW in Malawi.[165]   More thorough examinations of the frequency, 
duration of use, and dependent symptoms of marijuana use and longitudinal assessments of 
viral load among FSW would provide insight on the impact of heavy marijuana use, along 
with concurrent alcohol use, on HIV treatment outcomes. 
 Although this is the first study to examine the association between alcohol and 
marijuana use and sub-optimal HIV treatment outcomes among FSW in Malawi, the size of 
our sample is small and does not represent all HIV-infected FSW in Malawi.  Our modest 
sample size resulted in decreased estimate precision, limited power to detect small 
differences, and decreased ability to control confounding in multivariable analyses.  Our 
sample of FSW in Lilongwe were recruited from venues identified by our implementing 
partner, TfaC.  Since 2007, TfaC has implemented behavior change and advocacy programs 
to reduce poor sexual and reproductive health outcomes for FSW in Malawi.  It is likely that 
FSW within our sample may have previously participated in these programs, and therefore 
were not representative of more difficult-to-reach FSW in Malawi.  Despite these 
shortcomings, our study is the first to highlight the negative influence of substance use on 
HIV treatment outcomes for FSW in Malawi.  
Among HIV-infected FSW in Malawi, heavy alcohol use is common and associated 
with lack of ART use.  To improve HIV treatment engagement, targeted interventions for 
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HIV-infected FSW should prioritize the reduction of alcohol use, along with other 
substances. Further evaluations on the frequency and severity of marijuana use are needed to 
determine the additional role marijuana may play on sub-optimal HIV treatment outcomes.   
ART uptake strategies are critically needed for alcohol-using, ART-eligible FSW to induce 
viral suppression and ultimately, improve health outcomes and reduce transmission. 
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Table 10. Characteristics and substance use of ART-eligible female sex workers in Lilongwe, 
Malawi, July-September 2014, (N=96) 
  n (%) 
Age (years)    
     18-24  37 (39) 
     25-29  32 (34) 
     ≥30  27 (28) 
Education    
     Never attend or only primary school  66 (69) 
     Any secondary or more school  30 (31) 
Marital status    
Never married  10 (10) 
Married or co-habitating  3 (3) 
Separated, divorced, or widowed  83 (87) 
Housing    
Private house  13 (14) 
Bar or bottle shop  56 (58) 
Guesthouse or hotel  27 (28) 
Number of pregnancies    
     0  8 (8) 
     ≥1  88 (92) 
Number of financial dependents         
0  4 (4) 
≥1  92 (96) 
Depression    
     No probable depression  87 (91) 
     Probable depression  9 (9) 
Treated for an STI in prior 12 months    
     No  72 (75) 
     Yes  24 (25) 
Duration of sex work (years)  11 (11) 
     <1.0  15 (16) 
     1.0-1.9  17 (18) 
     2.0-2.9  53 (55) 
     ≥3.0    
Location for soliciting clients    
     Bar or bottle shop  11 (11) 
     Other  85 (89) 
Number of clients per weeka    
     <10  19 (20) 
     10-19  22 (23) 
     20-29  27 (28) 
     ≥30  27 (28) 
Condom use with client in prior 7 days    
Inconsistent  22 (23) 
Consistent  74 (77) 
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Ever had a client demand not using a condom 
during vaginal sex 
   
     No  40 (42) 
     Yes  56 (58) 
Alcohol use prior to last vaginal sex with client    
     No  68 (71) 
     Yes  28 (29) 
Substance use    
Alcohol use (AUDIT)    
     Non-hazardous drinking (score 0-6)  46 (48) 
     Hazardous drinking (score 7-15)  29 (30) 
     Harmful drinking (score 16-19)  10 (10) 
     Alcohol dependent (score ≥ 20)  11 (12) 
Marijuana use    
     No current marijuana use  76 (79) 
     Current marijuana useb  20 (21) 
a Missing data due to not knowing or refused to answer: number of clients in past 7 days: n=1 
b Current use defined as reported use in past 30 days
 89 
 
Figure 5. CD4 (A.) count and viral loads (B.) at the time of cross-sectional survey by 
reported ART use among ART-eligible HIV-infected female sex workers, (n=96); Box plots 
showing median (line), interquartile range (IQR; box), minimum (lower whiskers), and 
maximum (upper whiskers) 
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Table 11. Prevalence and association of alcohol and marijuana use with sub-optimal HIV care and treatment outcomes (not using 
ART and virally non-suppressed) among HIV-infected female sex workers in Lilongwe, Malawi 
 
 Reported ART 
use 
(N=96) Not using ART 
Viral suppression 
(N=72) Virally non-suppressed 
 Not 
using 
ART 
(n=24) 
Using 
ART 
(n=72) 
Unadjusted 
PR (95% CI) 
Adjusted 
PR (95% CI) 
Virally 
non-
suppressed 
(n=10) 
Virally 
suppressed 
(n=62) 
Unadjusted 
PR  
(95% CI) 
Adjusted 
PR  
(95% CI) 
Alcohol use (AUDIT)         
Non-
hazardous/hazardous 
(score ≤15) 
16 (21) 59 (79) 1.0 1.0 7 (12) 52 (88) 1.0 1.0 
Harmful/alcohol 
dependent (score ≥16) 
8 (38) 13 (62) 1.8 (0.9, 3.6) 1.9 (1.0, 3.8)b 3 (23) 10 (77) 2.0 (0.6, 6.5) -- 
         
Marijuana use         
No current marijuana 
use 
17 (23) 59 (78) 1.0 1.0 9 (15) 50 (85) 1.0 1.00 
Current marijuana usea 7 (35) 13 (65) 1.5 (0.8, 3.2) 1.9 (0.8, 4.6)c 1 (8) 12 (92) 0.5 (0.1, 3.6) -- 
PR=prevalence ratio; CI=confidence interval; AUDIT= Alcohol Use Disorder Identification Test 
a Current use defined as reported use in past 30 days 
b Adjusted for number of clients per week, housing, and duration in sex work (years) 
c Adjusted for treatment for an STI in the prior 12 months
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CHAPTER VII: DISCUSSION AND CONCLUSION 
 Substance use is highly prevalent among FSW globally.[1-7]  For FSW, substance 
use is often used to facilitate sex work and to cope with the stigma and stress associated with 
sex work.[1, 4, 8-10]  However, substance use can subsequently lead to high-risk sexual 
behaviors and increased HIV acquisition.[2, 11-13]   
The HIV prevalence among FSW is 12% globally and 37% in sub-Saharan 
Africa.[30]  FSW in Malawi have the highest HIV prevalence of nearly 70%.[141]  Given 
this very high prevalence, FSW must engage in HIV care and receive ART.  The expansion 
of ART for FSW can dramatically improve health outcomes and reduce onward 
transmission.[14-16]  To achieve the numerous benefits of expanded ART, HIV-infected 
FSW must receive a timely diagnosis, engage in care, adhere to treatment, and become 
virally suppressed.[19, 125]    Yet, little is known about FSW’s ability to engage in HIV 
testing, care, and treatment.[125, 126]   
 Substance use is likely an influential barrier to HIV testing and treatment outcomes 
for FSW in sub-Saharan Africa.  Clearly delineating the effect of substance on optimal 
engagement will inform strategies to enhance access to HIV testing, care, and treatment for 
FSW.  This dissertation was designed and implemented to evaluate whether commonly used 
substances significantly affects engagement in HIV testing and treatment among FSW in 
Lilongwe, Malawi. 
 
 
 92 
 
Summary of findings 
 Our work was conducted in a population of 200 FSW in Lilongwe, Malawi, where the 
HIV burden is one of the highest globally.  We sought to evaluate and compare the 
associations between substance use and engagement within each stage along the HIV care 
continuum among FSW, a key population disproportionately affected by HIV.  For our study, 
we conducted a behavioral survey, HIV rapid testing, CD4 cell count assessments, and HIV-
1 RNA levels measurements to achieve our three aims. 
 In our first aim, we characterized the HIV care continuum for our sample of FSW in 
Malawi.  Our studies was one of the first studies to characterize the HIV care continuum 
among this key population.  Among our sample of 200 FSW, we found the HIV 
seroprevalence was very high at 69% (n=138), with 20% as newly diagnosed through our 
study.  Among all HIV-infected FSW, nearly 70% reported a history of care, over 50% 
reported current ART use, and 45% were virally suppressed.  Specifically among the FSW 
who reported current ART use, we identified 86% were virally suppressed at the time of our 
study.  We also observed that transmission risk behaviors, such as duration in sex work, 
number of weekly clients, inconsistent condom use during vaginal sex with clients, were not 
associated with the HIV care continuum outcomes. 
 For our second aim, we focused on the relationship between alcohol and marijuana 
use, alone and together, with HIV infection awareness among HIV-infected FSW in 
Lilongwe, Malawi.  Of the 138 HIV-infected FSW, 80% were aware of their HIV infection 
and 20% were unaware of their HIV infection.  Alcohol use was very common among HIV-
infected FSW in our sample.  We identified a dose-response relationship between increased 
alcohol use and lack of HIV infection awareness.  In multivariable analysis, alcohol 
dependency was associated with lack of HIV infection awareness, adjusting for adjusting for 
 93 
 
duration in sex work, alcohol use prior to last vaginal sex with a client, and number of clients 
per week.  Among our sample of HIV-infected FSW, marijuana use, alone and together with 
alcohol, was not significantly associated with lack of HIV infection awareness. 
For our third aim, we evaluated the association between alcohol and marijuana use 
and sub-optimal HIV treatment outcomes, including lack of ART use among ART-eligible 
and viral nonsuppression, among HIV-infected FSW in Lilongwe, Malawi.  Among the FSW 
who ART-eligible, only about 30% were not using ART.  Of the HIV-infected FSW, heavy 
levels of alcohol use, including harmful drinking and alcohol dependency, and current 
marijuana use associated with sub-optimal HIV treatment outcomes.  Specifically, FSW who 
were harmful drinkers or alcohol dependent were two times as likely to not use ART 
compared to FSW who were not hazardous or hazardous drinkers, adjusting for number of 
clients per week, housing, and duration in sex work.  Marijuana use was uncommon, with 
only 20% of ART-eligible FSW reporting current marijuana use.  However, marijuana use 
was weakly associated with using ART among ART-eligible FSW in Lilongwe, Malawi.     
Public health implications 
 Together, our three studies have contributed to our understanding of the co-occurring 
substance use and HIV epidemics among the understudied and underserved FSW in sub-
Saharan Africa.  Our findings emphasize that despite decades of prevention activities, FSW 
in Malawi remain heavily burdened by HIV.[127]   Substance use, specifically alcohol use, 
among FSW is common and is an important barrier to achieving optimal HIV care continuum 
outcomes necessary for optimizing health outcomes and preventing ongoing transmission. 
Given the exceedingly high prevalence of HIV among FSW, Malawi must consider 
the adoption of targeted universal testing and treatment strategies for FSW.  HIV testing is 
the critical initial step towards engaging in HIV care and treatment.  Frequent HIV testing for 
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FSW is necessary for a timely diagnosis and prevention of ongoing transmission.  FSW who 
remain unware of their HIV infection miss opportunities for HIV care entry, resulting in later 
initiation of ART and increased risk for AIDS progression.[130]  The proportion of FSW in 
our study who tested outside the current recommendation of yearly HIV testing, underscores 
the need for frequent outreach to encourage rapid HIV testing to capture highly active FSW. 
Most ART-eligible FSW in our sample were using ART.  Expanded ART programs 
in Malawi have been successful in improving access to ART for HIV-infected persons, 
including FSW.  These programs have included the provision of ART to all pregnant or 
breastfeeding HIV-infected women (Option B+) beginning in July 2011 and early initiation 
of ART (CD4 count ≤500 cells/mm3) in April 2014.[131]  The expansion of ART is likely 
responsible for our high proportion of HIV-infected ART-eligible FSW receiving ART.  
 Initiation of ART for all HIV-infected FSW in Malawi is critical for the prevention of 
ongoing transmission to HIV-uninfected partners.  Among all the HIV-infected FSW in our 
study, nearly half were not on ART and therefore, not receiving the numerous clinical, 
immunological, and transmission benefits of therapy.  Timely uptake of ART can 
dramatically improve health outcomes and prevent onward transmission.[14-16]   
Interventions are urgently needed that focus on increasing access and adherence to ART for 
FSW in sub-Saharan Africa.    
 Our findings highlight that substance use, particularly alcohol use, is common. 
Overall within our sample, many FSW were consuming alcohol with a substantial proportion 
consuming alcohol heavily.  In general, FSW have higher rates of hazardous alcohol 
consumption patterns than the general population due to their specific occupational and 
environmental factors.[4, 20, 46]   Alcohol serving venues tend to be the location where FSW 
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solicit clients, in return making alcohol easily accessible.[4, 29, 166]  Abstaining from 
alcohol consumption is challenging as male clients typically purchase alcohol prior to sexual 
activity with the FSW.[167-169]   Alcohol consumption also serves as a coping mechanism 
for FSW, as a way to handle stress associated from their work.[4, 169, 170]  Identification of 
heavy alcohol use provides a point of intervention for FSW in Malawi.   
 We observed that heavy alcohol use leads to lack of HIV infection awareness, low 
ART use among ART-eligible, and viral nonsuppression.  Optimal ART use and viral 
suppression are necessary for the success of treatment as prevention interventions.  In light of 
newly identified biomedical prevention interventions, there is increasing interest of 
preventing HIV at the population level by treating HIV-infected individuals.[171]  Modeling 
shows that prioritizing ART uptake to FSW could have a significant effect on HIV 
transmission, if FSW properly engage and adhere to treatment.[19]  Given our documented 
association between heavy alcohol use and sub-optimal HIV testing and treatment outcomes, 
heavy alcohol use will likely prevent the potential success of treatment as prevention 
interventions.  Strategies that improve uptake of HIV testing, care, and treatment and address 
substance use must be strongly considered FSW in Malawi. 
 Our findings improve the limited existing knowledge of marijuana use among FSW in 
sub-Saharan Africa.  Marijuana use was uncommon among our sample FSW and was weakly 
associated between marijuana use and HIV testing and treatment.  This was unexpected given 
marijuana use, like alcohol use, can affect engagement in HIV prevention and treatment 
services by decreasing cognitive abilities.  The weak association may likely be the result of 
our selection of FSW.  FSW in our sample were predominantly living and working at bars 
and bottle shops where alcohol is more readily available than marijuana.  Additionally, our 
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estimate of marijuana use was based on current marijuana use which limited our ability to 
measure the severity of marijuana use.  Our results encourage careful consideration for the 
best approaches for designing studies focused on marijuana use and engagement in HIV 
testing, care and treatment among FSW. 
Future directions 
 Prospective, longitudinal national surveillance programs will be critical to estimate 
the dynamic, multidirectional movement of engaging in HIV testing, care, and treatment for 
both venue-based and street-based FSW in Malawi.  The HIV care continuum provides an 
informative framework for cross-sectionally characterizing HIV testing, care, and treatment.  
Unfortunately, this framework, alone, cannot appropriately capture the dynamic nature of 
engaging and disengaging in sex work and HIV prevention and care services.  Qualitatively, 
we found that FSW in Lilongwe engage and disengage with sex work multiple times 
throughout their young lives.  Furthermore, the traditional continuum framework does not 
clearly characterize important processes, such as care re-engagement and viral re-suppression 
that may occur for some HIV-infected FSW.[126]  Enhanced national surveillance programs 
for FSW in Malawi will provide a better understanding and monitoring of the HIV epidemic 
and engagement in HIV testing, care, and treatment. 
 A better understanding is needed of the underlying pathways of the relationships of 
substance use and engagement in HIV testing, care, and treatment among FSW.  Additional 
research should employ longitudinal assessments of substance use engagement throughout 
the HIV care continuum.  In particular, future work should examine how substance use 
changes over time during sex work, document the duration and severity of substance use.  
Further research should also determine appropriate points of substance use focused 
interventions to improve uptake of HIV testing, care, and treatment among FSW.   
 97 
 
Additionally, research should include various FSW typology, such as venue-based and street-
based FSW.  Including these types of FSW will assess potential differences by type of the 
association between substance use and HIV care continuum outcomes.  Together, these 
future studies can inform combination substance use and HIV treatment as prevention 
interventions for FSW. 
 Interventions are urgently needed for FSW in Malawi to reduce substance use and 
promote a timely HIV diagnosis, engagement in care, adherence to ART, and viral 
suppression.  The design of combination interventions must utilize the most strategic 
approaches to maximize uptake of effective substance use and HIV treatment strategies.  One 
approach may be integrating substance use treatment into current HIV prevention and 
treatment services.  Successfully integrating these services will benefit service providers and 
reduce costs within this already resource-limited settings.  An additional approach if 
resources allow, these interventions should employ a venue-based approach to provide 
substance use treatment and HIV testing, care, and treatment for FSW.  Targeted strategies 
for highly active FSW within venues must be explored and implemented to effectively reach 
FSW. 
Conclusions 
 Substance use is common among FSW in Malawi, where the HIV prevalence among 
FSW remains the highest globally.  Alcohol use, in particular, is an important barrier to 
reaching optimal HIV care continuum outcomes.  Increasing levels of alcohol use is 
associated with lack of HIV infection awareness.  FSW who are heavy alcohol users, such as 
harmful drinkers and alcohol dependent, are more likely to not use ART and be virally 
nonsuppressed.  Further evaluations on the frequency and severity of marijuana use are 
needed to determine the additional affect marijuana may have on HIV testing and treatment.  
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FSW in Malawi with sub-optimal HIV testing and treatment outcomes will not receive the 
full clinical, immunological, and transmission prevention benefits of therapy.  Targeted 
combination interventions for HIV-infected FSW must prioritize the reduction of alcohol use, 
along with other substances, to optimize HIV testing and treatment for FSW.   
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